ACAD9.md
... ...
@@ -32,7 +32,7 @@ Due to [minimal support](ACAD9#representative-mutation) in the original primary
32 32
33 33
34 34
35
-[[include:browser_ACAD9.md]]
35
+[[include:tables/browser_ACAD9.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/ACAD9_by_pathology.svg)
ACE.md
... ...
@@ -33,7 +33,7 @@ Due to [minimal support](ACE#representative-mutation) in the original primary da
33 33
34 34
35 35
36
-[[include:browser_ACE.md]]
36
+[[include:tables/browser_ACE.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/ACE_by_pathology.svg)
ACTB.md
... ...
@@ -56,7 +56,7 @@ ACTB is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)
56 56
| chr7 | 5568923 | T>C | N78D |
57 57
| chr7 | 5568920 | A>C | W79G |
58 58
59
-[[include:browser_ACTB.md]]
59
+[[include:tables/browser_ACTB.md]]
60 60
61 61
## Expression
62 62
![](images/gene_expression/ACTB_by_pathology.svg)
ACTG1.md
... ...
@@ -41,7 +41,7 @@ The function of mutations in ACTB and ACTG1 have not yet been determined.[@witje
41 41
42 42
43 43
44
-[[include:browser_ACTG1.md]]
44
+[[include:tables/browser_ACTG1.md]]
45 45
46 46
## Expression
47 47
![](images/gene_expression/ACTG1_by_pathology.svg)
ADAMTS1.md
... ...
@@ -38,7 +38,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a
38 38
39 39
40 40
41
-[[include:browser_ADAMTS1.md]]
41
+[[include:tables/browser_ADAMTS1.md]]
42 42
43 43
## Expression
44 44
![](images/gene_expression/ADAMTS1_by_pathology.svg)
ADAMTS5.md
... ...
@@ -23,7 +23,7 @@ nocite: |
23 23
[[include:tables/dnds_ADAMTS5.md]]
24 24
25 25
26
-[[include:browser_ADAMTS5.md]]
26
+[[include:tables/browser_ADAMTS5.md]]
27 27
28 28
## Expression
29 29
![](images/gene_expression/ADAMTS5_by_pathology.svg)
ADNP.md
... ...
@@ -24,7 +24,7 @@ nocite: |
24 24
25 25
26 26
27
-[[include:browser_ADNP.md]]
27
+[[include:tables/browser_ADNP.md]]
28 28
29 29
## Expression
30 30
![](images/gene_expression/ADNP_by_pathology.svg)
AGO4.md
... ...
@@ -22,7 +22,7 @@ nocite: |
22 22
23 23
24 24
25
-[[include:browser_AGO4.md]]
25
+[[include:tables/browser_AGO4.md]]
26 26
27 27
## Expression
28 28
![](images/gene_expression/AGO4_by_pathology.svg)
AICDA.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_AICDA.md]]
32
+[[include:tables/browser_AICDA.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/AICDA_by_pathology.svg)
ALPK2.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
| :---:| :---: | :--: | :---: |
36 36
| chr18 | 56203836 | C>T | V1195M |
37 37
38
-[[include:browser_ALPK2.md]]
38
+[[include:tables/browser_ALPK2.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/ALPK2_by_pathology.svg)
ANK2.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
27 27
28
-[[include:browser_ANK2.md]]
28
+[[include:tables/browser_ANK2.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/ANK2_by_pathology.svg)
ANKRD12.md
... ...
@@ -29,7 +29,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a
29 29
30 30
[[include:tables/dnds_ANKRD12.md]]
31 31
32
-[[include:browser_ANKRD12.md]]
32
+[[include:tables/browser_ANKRD12.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/ANKRD12_by_pathology.svg)
ANKRD17.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
[[include:tables/dnds_ANKRD17.md]]
27 27
28 28
29
-[[include:browser_ANKRD17.md]]
29
+[[include:tables/browser_ANKRD17.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/ANKRD17_by_pathology.svg)
ARHGEF1.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
27 27
28 28
29
-[[include:browser_ARHGEF1.md]]
29
+[[include:tables/browser_ARHGEF1.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/ARHGEF1_by_pathology.svg)
ARID1A.md
... ...
@@ -32,7 +32,7 @@ Driver mutations affecting this gene have been experimentally demonstrated to ca
32 32
33 33
[[include:tables/dnds_ARID1A.md]]
34 34
35
-[[include:browser_ARID1A.md]]
35
+[[include:tables/browser_ARID1A.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/ARID1A_by_pathology.svg)
ARID1B.md
... ...
@@ -36,7 +36,7 @@ nocite: |
36 36
[[include:tables/dnds_ARID1B.md]]
37 37
38 38
39
-[[include:browser_ARID1B.md]]
39
+[[include:tables/browser_ARID1B.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/ARID1B_by_pathology.svg)
ARID5B.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
32 32
[[include:tables/dnds_ARID5B.md]]
33 33
34
-[[include:browser_ARID5B.md]]
34
+[[include:tables/browser_ARID5B.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/ARID5B_by_pathology.svg)
ATM.md
... ...
@@ -34,7 +34,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
34 34
[[include:tables/dnds_ATM.md]]
35 35
36 36
37
-[[include:browser_ATM.md]]
37
+[[include:tables/browser_ATM.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/ATM_by_pathology.svg)
ATP11C.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_ATP11C.md]]
32
+[[include:tables/browser_ATP11C.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/ATP11C_by_pathology.svg)
ATP2C2.md
... ...
@@ -38,7 +38,7 @@ Due to [minimal support](ATP2C2#representative-mutation) in the original primary
38 38
39 39
40 40
41
-[[include:browser_ATP2C2.md]]
41
+[[include:tables/browser_ATP2C2.md]]
42 42
43 43
## Expression
44 44
![](images/gene_expression/ATP2C2_by_pathology.svg)
ATP6AP1.md
... ...
@@ -21,7 +21,7 @@ nocite: |
21 21
22 22
[[include:tables/dnds_ATP6AP1.md]]
23 23
24
-[[include:browser_ATP6AP1.md]]
24
+[[include:tables/browser_ATP6AP1.md]]
25 25
26 26
## Expression
27 27
![](images/gene_expression/ATP6AP1_by_pathology.svg)
ATP6V1A.md
... ...
@@ -33,7 +33,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a
33 33
| :---:| :---: | :--: | :---: |
34 34
| chr3 | 113528218 | G>A | D600N |
35 35
36
-[[include:browser_ATP6V1A.md]]
36
+[[include:tables/browser_ATP6V1A.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/ATP6V1A_by_pathology.svg)
ATP6V1B2.md
... ...
@@ -31,7 +31,7 @@ Driver mutations affecting this gene in FL have been experimentally demonstrated
31 31
| :---:| :---: | :--: | :---: |
32 32
| chr8 | 20074768 | G>A | R400Q |
33 33
34
-[[include:browser_ATP6V1B2.md]]
34
+[[include:tables/browser_ATP6V1B2.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/ATP6V1B2_by_pathology.svg)
ATR.md
... ...
@@ -30,7 +30,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re
30 30
[[include:tables/dnds_ATR.md]]
31 31
32 32
33
-[[include:browser_ATR.md]]
33
+[[include:tables/browser_ATR.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/ATR_by_pathology.svg)
B2M.md
... ...
@@ -60,7 +60,7 @@ B2M mutations in B-cell lymphomas, particularly in DLBCL and PMBCL, lead to redu
60 60
| chr15 | 45003781 | C>T | L13F |
61 61
| chr15 | 45003782 | T>C | L13P |
62 62
63
-[[include:browser_B2M.md]]
63
+[[include:tables/browser_B2M.md]]
64 64
65 65
## Expression
66 66
![](images/gene_expression/B2M_by_pathology.svg)
BACH2.md
... ...
@@ -36,7 +36,7 @@ Driver mutations affecting this gene in BL have been experimentally demonstrated
36 36
|chr6 |90981034 |91016134|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr6%3A90981034%2D91016134)|NA |
37 37
38 38
39
-[[include:browser_BACH2.md]]
39
+[[include:tables/browser_BACH2.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/BACH2_by_pathology.svg)
BCL10.md
... ...
@@ -47,7 +47,7 @@ BCL10 missense mutations in the CARD domain and truncating mutations have distin
47 47
| chr1 | 85733390 | G>A | Q208* |
48 48
| chr1 | 85733386 | A>C | L209* |
49 49
50
-[[include:browser_BCL10.md]]
50
+[[include:tables/browser_BCL10.md]]
51 51
52 52
## Expression
53 53
BCL11A.md
... ...
@@ -50,7 +50,7 @@ BCL11A (B-cell lymphoma/leukemia 11A) is a transcription factor involved in the
50 50
| chr2 | 60780368 | C>T | S13N |
51 51
| chr2 | 60780368 | C>G | S13T |
52 52
53
-[[include:browser_BCL11A.md]]
53
+[[include:tables/browser_BCL11A.md]]
54 54
55 55
## Expression
56 56
![](images/gene_expression/BCL11A_by_pathology.svg)
BCL2.md
... ...
@@ -53,7 +53,7 @@ Although missense mutations may not be under positive selective pressure in the
53 53
| chr18 | 60985835 | T>C | K22R |
54 54
| chr18 | 60985834 | CT>TC | K22R |
55 55
56
-[[include:browser_BCL2.md]]
56
+[[include:tables/browser_BCL2.md]]
57 57
58 58
## Expression
59 59
![](images/gene_expression/BCL2_by_pathology.svg)
BCL6.md
... ...
@@ -63,7 +63,7 @@ Driver mutations affecting this gene in BL/FL/DLBCL have been experimentally dem
63 63
| chr3 | 187443345 | C>T | R594Q |
64 64
| chr3 | 187443342 | A>T | I595N |
65 65
66
-[[include:browser_BCL6.md]]
66
+[[include:tables/browser_BCL6.md]]
67 67
68 68
## Expression
69 69
![](images/gene_expression/BCL6_by_pathology.svg)
BCL7A.md
... ...
@@ -46,7 +46,7 @@ Driver mutations affecting this gene in BL/DLBCL/FL have been experimentally dem
46 46
|chr12 |122456912 |122464036|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr12%3A122456912%2D122464036)|poised_promoter |
47 47
48 48
49
-[[include:browser_BCL7A.md]]
49
+[[include:tables/browser_BCL7A.md]]
50 50
51 51
## Expression
52 52
![](images/gene_expression/BCL7A_by_pathology.svg)
BCOR.md
... ...
@@ -45,7 +45,7 @@ BCOR acts as a co-repressor of BCL6, and mutations in BCOR could impair its bind
45 45
| :---:| :---: | :--: | :---: |
46 46
| chrX | 39921444 | T>C | N1459S |
47 47
48
-[[include:browser_BCOR.md]]
48
+[[include:tables/browser_BCOR.md]]
49 49
50 50
## Expression
51 51
![](images/gene_expression/BCOR_by_pathology.svg)
BCR.md
... ...
@@ -50,7 +50,7 @@ BCR (Breakpoint Cluster Region Protein) is one of [a number of genes](https://gi
50 50
| chr22 | 23523359 | A>C | D71A |
51 51
| chr22 | 23523374 | G>A | G76D |
52 52
53
-[[include:browser_BCR.md]]
53
+[[include:tables/browser_BCR.md]]
54 54
55 55
## Expression
56 56
![](images/gene_expression/BCR_by_pathology.svg)
BIRC3.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_BIRC3.md]]
35
+[[include:tables/browser_BIRC3.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/BIRC3_by_pathology.svg)
BIRC6.md
... ...
@@ -35,7 +35,7 @@ BIRC6, as a negative regulator of non-canonical NF-κB signaling, is implicated
35 35
| :---:| :---: | :--: | :---: |
36 36
| chr2 | 32740138 | T>A | C3550* |
37 37
38
-[[include:browser_BIRC6.md]]
38
+[[include:tables/browser_BIRC6.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/BIRC6_by_pathology.svg)
BLK.md
... ...
@@ -36,7 +36,7 @@ nocite: |
36 36
|chr8 |11347723 |11355318|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr8%3A11347723%2D11355318)|strong_enhancer |
37 37
38 38
39
-[[include:browser_BLK.md]]
39
+[[include:tables/browser_BLK.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/BLK_by_pathology.svg)
BMP7.md
... ...
@@ -42,7 +42,7 @@ nocite: |
42 42
| chr20 | 55840918 | G>C | Y87* |
43 43
| chr20 | 55840913 | G>T | A89D |
44 44
45
-[[include:browser_BMP7.md]]
45
+[[include:tables/browser_BMP7.md]]
46 46
47 47
## Expression
48 48
![](images/gene_expression/BMP7_by_pathology.svg)
BRAF.md
... ...
@@ -53,7 +53,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
53 53
| chr7 | 140453136 | A>T | V600E |
54 54
| chr7 | 140453132 | T>G | K601N |
55 55
56
-[[include:browser_BRAF.md]]
56
+[[include:tables/browser_BRAF.md]]
57 57
58 58
## Expression
59 59
![](images/gene_expression/BRAF_by_pathology.svg)
BRD4.md
... ...
@@ -36,7 +36,7 @@ Due to [minimal support](BRD4#representative-mutation) in the original primary d
36 36
37 37
38 38
39
-[[include:browser_BRD4.md]]
39
+[[include:tables/browser_BRD4.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/BRD4_by_pathology.svg)
BRINP3.md
... ...
@@ -35,7 +35,7 @@ Details[@drevalRevisitingReddyDLBCL2023]
35 35
[[include:tables/dnds_BRINP3.md]]
36 36
37 37
38
-[[include:browser_BRINP3.md]]
38
+[[include:tables/browser_BRINP3.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/BRINP3_by_pathology.svg)
BTBD3.md
... ...
@@ -29,7 +29,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero
29 29
30 30
[[include:tables/dnds_BTBD3.md]]
31 31
32
-[[include:browser_BTBD3.md]]
32
+[[include:tables/browser_BTBD3.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/BTBD3_by_pathology.svg)
BTG1.md
... ...
@@ -72,7 +72,7 @@ Another study demonstrated that specific BTG1 mutations afford germinal center (
72 72
| chr12 | 92538217 | T>C | Y52C |
73 73
| chr12 | 92538215 | T>C | K53E |
74 74
75
-[[include:browser_BTG1.md]]
75
+[[include:tables/browser_BTG1.md]]
76 76
77 77
## Expression
78 78
![](images/gene_expression/BTG1_by_pathology.svg)
BTG2.md
... ...
@@ -43,7 +43,7 @@ BTG2 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)
43 43
44 44
45 45
46
-[[include:browser_BTG2.md]]
46
+[[include:tables/browser_BTG2.md]]
47 47
48 48
## Expression
49 49
![](images/gene_expression/BTG2_by_pathology.svg)
BTK.md
... ...
@@ -29,7 +29,7 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons
29 29
30 30
[[include:tables/dnds_BTK.md]]
31 31
32
-[[include:browser_BTK.md]]
32
+[[include:tables/browser_BTK.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/BTK_by_pathology.svg)
C6orf27.md
... ...
@@ -26,7 +26,7 @@ Due to [minimal support](C6orf27#representative-mutation) in the original primar
26 26
27 27
[[include:tables/BL_C6orf27.md]]
28 28
29
-[[include:browser_C6orf27.md]]
29
+[[include:tables/browser_C6orf27.md]]
30 30
31 31
<!-- ORIGIN: loveGeneticLandscapeMutations2012 -->
32 32
<!-- BL: loveGeneticLandscapeMutations2012 -->
CAD.md
... ...
@@ -42,7 +42,7 @@ Due to [minimal support](CAD#representative-mutation) in the original primary da
42 42
| :---:| :---: | :--: | :---: |
43 43
| chr2 | 27455966 | T>A | Y983* |
44 44
45
-[[include:browser_CAD.md]]
45
+[[include:tables/browser_CAD.md]]
46 46
47 47
## Expression
48 48
![](images/gene_expression/CAD_by_pathology.svg)
CADPS2.md
... ...
@@ -30,7 +30,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a
30 30
[[include:tables/dnds_CADPS2.md]]
31 31
32 32
33
-[[include:browser_CADPS2.md]]
33
+[[include:tables/browser_CADPS2.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/CADPS2_by_pathology.svg)
CARD11.md
... ...
@@ -57,7 +57,7 @@ The functional effect of CARD11 mutations in DLBCL was explored in the original
57 57
| chr7 | 2977602 | T>G | Y361S |
58 58
| chr7 | 2977602 | T>C | Y361C |
59 59
60
-[[include:browser_CARD11.md]]
60
+[[include:tables/browser_CARD11.md]]
61 61
62 62
## Expression
63 63
![](images/gene_expression/CARD11_by_pathology.svg)
CARD4.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
[[include:tables/dnds_CARD4.md]]
31 31
32
-[[include:browser_CARD4.md]]
32
+[[include:tables/browser_CARD4.md]]
33 33
34 34
<!-- ORIGIN: loveGeneticLandscapeMutations2012 -->
35 35
<!-- BL: loveGeneticLandscapeMutations2012 -->
CASP8.md
... ...
@@ -33,7 +33,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re
33 33
34 34
35 35
36
-[[include:browser_CASP8.md]]
36
+[[include:tables/browser_CASP8.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/CASP8_by_pathology.svg)
CBLB.md
... ...
@@ -34,7 +34,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re
34 34
[[include:tables/dnds_CBLB.md]]
35 35
36 36
37
-[[include:browser_CBLB.md]]
37
+[[include:tables/browser_CBLB.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/CBLB_by_pathology.svg)
CCL4.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_CCL4.md]]
32
+[[include:tables/browser_CCL4.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/CCL4_by_pathology.svg)
CCND1.md
... ...
@@ -23,7 +23,7 @@ nocite: |
23 23
[[include:tables/dnds_CCND1]]
24 24
-->
25 25
26
-[[include:browser_CCND1.md]]
26
+[[include:tables/browser_CCND1.md]]
27 27
28 28
## Expression
29 29
![](images/gene_expression/CCND1_by_pathology.svg)
CCND3.md
... ...
@@ -76,7 +76,7 @@ The dysregulation of CCND3 due to these mutations contributes to the oncogenic p
76 76
| chr6 | 41903682 | A>T | L292Q |
77 77
| chr6 | 41903682 | A>C | L292R |
78 78
79
-[[include:browser_CCND3.md]]
79
+[[include:tables/browser_CCND3.md]]
80 80
81 81
## Expression
82 82
![](images/gene_expression/CCND3_by_pathology.svg)
CCNF.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
[[include:tables/dnds_CCNF.md]]
26 26
27 27
28
-[[include:browser_CCNF.md]]
28
+[[include:tables/browser_CCNF.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/CCNF_by_pathology.svg)
CCT6B.md
... ...
@@ -37,7 +37,7 @@ Due to [minimal support](CCT6B#representative-mutations) in the original primary
37 37
38 38
39 39
40
-[[include:browser_CCT6B.md]]
40
+[[include:tables/browser_CCT6B.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/CCT6B_by_pathology.svg)
CD22.md
... ...
@@ -30,7 +30,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re
30 30
[[include:tables/dnds_CD22.md]]
31 31
32 32
33
-[[include:browser_CD22.md]]
33
+[[include:tables/browser_CD22.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/CD22_by_pathology.svg)
CD274.md
... ...
@@ -32,7 +32,7 @@ Although rare, mutations have the potential to impact PD-L1 expression and could
32 32
33 33
34 34
35
-[[include:browser_CD274.md]]
35
+[[include:tables/browser_CD274.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/CD274_by_pathology.svg)
CD36.md
... ...
@@ -38,7 +38,7 @@ CD36 is a transmembrane glycoprotein involved in fatty acid metabolism, glucose
38 38
<!-- ORIGIN: pasqualucciAnalysisCodingGenome2011 -->
39 39
<!-- DLBCL: pasqualucciAnalysisCodingGenome2011 -->
40 40
41
-[[include:browser_CD36.md]]
41
+[[include:tables/browser_CD36.md]]
42 42
43 43
[[include:tables/mermaid_CD36.md]]
44 44
CD44.md
... ...
@@ -34,7 +34,7 @@ nocite: |
34 34
35 35
36 36
37
-[[include:browser_CD44.md]]
37
+[[include:tables/browser_CD44.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/CD44_by_pathology.svg)
CD58.md
... ...
@@ -30,7 +30,7 @@ This is often accompanied by mutations in the β2-Microglobulin gene, which furt
30 30
31 31
[[include:tables/dnds_CD58.md]]
32 32
33
-[[include:browser_CD58.md]]
33
+[[include:tables/browser_CD58.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/CD58_by_pathology.svg)
CD70.md
... ...
@@ -46,7 +46,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
46 46
| chr19 | 6590137 | G>A | A58V |
47 47
| chr19 | 6590116 | G>A | T65I |
48 48
49
-[[include:browser_CD70.md]]
49
+[[include:tables/browser_CD70.md]]
50 50
51 51
## Expression
52 52
![](images/gene_expression/CD70_by_pathology.svg)
CD74.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_CD74.md]]
32
+[[include:tables/browser_CD74.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/CD74_by_pathology.svg)
CD79A.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
| chr19 | 42384963 | T>A | Y199* |
36 36
| chr19 | 42384963 | T>G | Y199* |
37 37
38
-[[include:browser_CD79A.md]]
38
+[[include:tables/browser_CD79A.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/CD79A_by_pathology.svg)
CD79B.md
... ...
@@ -61,7 +61,7 @@ Mutations at Y196 enhance B-cell receptor (BCR) signaling by preventing the nega
61 61
| chr17 | 62006603 | G>A | H226Y |
62 62
| chr17 | 62006603 | G>T | H226N |
63 63
64
-[[include:browser_CD79B.md]]
64
+[[include:tables/browser_CD79B.md]]
65 65
66 66
## Expression
67 67
![](images/gene_expression/CD79B_by_pathology.svg)
CD83.md
... ...
@@ -41,7 +41,7 @@ Mutations in this gene were first described in DLBCL in 2013 by Morin et al[@mor
41 41
42 42
43 43
44
-[[include:browser_CD83.md]]
44
+[[include:tables/browser_CD83.md]]
45 45
46 46
## Expression
47 47
![](images/gene_expression/CD83_by_pathology.svg)
CDC73.md
... ...
@@ -36,7 +36,7 @@ Mutations in this gene were first described in BL in 2012 by Love et al[@loveGen
36 36
37 37
[[include:tables/dnds_CDC73.md]]
38 38
39
-[[include:browser_CDC73.md]]
39
+[[include:tables/browser_CDC73.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/CDC73_by_pathology.svg)
CDH17.md
... ...
@@ -36,7 +36,7 @@ Due to [minimal support](CDH17#representative-mutations) in the original primary
36 36
37 37
38 38
39
-[[include:browser_CDH17.md]]
39
+[[include:tables/browser_CDH17.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/CDH17_by_pathology.svg)
CDH8.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
27 27
28 28
29
-[[include:browser_CDH8.md]]
29
+[[include:tables/browser_CDH8.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/CDH8_by_pathology.svg)
CDH9.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_CDH9.md]]
32
+[[include:tables/browser_CDH9.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/CDH9_by_pathology.svg)
CDKN2A.md
... ...
@@ -41,7 +41,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
41 41
| :---:| :---: | :--: | :---: |
42 42
| chr9 | 21971120 | G>A | R80* |
43 43
44
-[[include:browser_CDKN2A.md]]
44
+[[include:tables/browser_CDKN2A.md]]
45 45
46 46
## Expression
47 47
CDKN2C.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_CDKN2C.md]]
30
+[[include:tables/browser_CDKN2C.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/CDKN2C_by_pathology.svg)
CHD1.md
... ...
@@ -34,7 +34,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re
34 34
[[include:tables/dnds_CHD1.md]]
35 35
36 36
37
-[[include:browser_CHD1.md]]
37
+[[include:tables/browser_CHD1.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/CHD1_by_pathology.svg)
CHD4.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_CHD4.md]]
30
+[[include:tables/browser_CHD4.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/CHD4_by_pathology.svg)
CHD8.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
[[include:tables/dnds_CHD8.md]]
30 30
31
-[[include:browser_CHD8.md]]
31
+[[include:tables/browser_CHD8.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/CHD8_by_pathology.svg)
CHST2.md
... ...
@@ -34,7 +34,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re
34 34
[[include:tables/dnds_CHST2.md]]
35 35
36 36
37
-[[include:browser_CHST2.md]]
37
+[[include:tables/browser_CHST2.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/CHST2_by_pathology.svg)
CIITA.md
... ...
@@ -39,7 +39,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
39 39
40 40
41 41
42
-[[include:browser_CIITA.md]]
42
+[[include:tables/browser_CIITA.md]]
43 43
44 44
## Expression
45 45
![](images/gene_expression/CIITA_by_pathology.svg)
CILP.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
27 27
28 28
29
-[[include:browser_CILP.md]]
29
+[[include:tables/browser_CILP.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/CILP_by_pathology.svg)
CNOT2.md
... ...
@@ -29,7 +29,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a
29 29
30 30
[[include:tables/dnds_CNOT2.md]]
31 31
32
-[[include:browser_CNOT2.md]]
32
+[[include:tables/browser_CNOT2.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/CNOT2_by_pathology.svg)
CNTNAP5.md
... ...
@@ -30,7 +30,7 @@ Mutations in this gene were first described in DLBCL in 2013 by Morin et al.[@mo
30 30
[[include:tables/dnds_CNTNAP5.md]]
31 31
32 32
33
-[[include:browser_CNTNAP5.md]]
33
+[[include:tables/browser_CNTNAP5.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/CNTNAP5_by_pathology.svg)
COL11A1.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
31 31
32 32
33
-[[include:browser_COL11A1.md]]
33
+[[include:tables/browser_COL11A1.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/COL11A1_by_pathology.svg)
COL16A1.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
31 31
32 32
33
-[[include:browser_COL16A1.md]]
33
+[[include:tables/browser_COL16A1.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/COL16A1_by_pathology.svg)
COL4A2.md
... ...
@@ -38,7 +38,7 @@ Due to [minimal support](COL4A2#representative-mutations) in the original primar
38 38
39 39
40 40
41
-[[include:browser_COL4A2.md]]
41
+[[include:tables/browser_COL4A2.md]]
42 42
43 43
## Expression
44 44
![](images/gene_expression/COL4A2_by_pathology.svg)
COQ7.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_COQ7.md]]
32
+[[include:tables/browser_COQ7.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/COQ7_by_pathology.svg)
CPNE8.md
... ...
@@ -29,7 +29,7 @@ Mutations in this gene were first described in FL in 2021 by Hübschmann et al.[
29 29
30 30
31 31
32
-[[include:browser_CPNE8.md]]
32
+[[include:tables/browser_CPNE8.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/CPNE8_by_pathology.svg)
CPXM2.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_CPXM2.md]]
31
+[[include:tables/browser_CPXM2.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/CPXM2_by_pathology.svg)
CREBBP.md
... ...
@@ -68,7 +68,7 @@ Mutations in CREBBP and EP300 affect a common pathway and have been described as
68 68
| chr16 | 3786703 | T>A | Y1503F |
69 69
| chr16 | 3786691 | A>G | L1507P |
70 70
71
-[[include:browser_CREBBP.md]]
71
+[[include:tables/browser_CREBBP.md]]
72 72
73 73
## Expression
74 74
![](images/gene_expression/CREBBP_by_pathology.svg)
CRIP1.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_CRIP1.md]]
32
+[[include:tables/browser_CRIP1.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/CRIP1_by_pathology.svg)
CTCF.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_CTCF.md]]
35
+[[include:tables/browser_CTCF.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/CTCF_by_pathology.svg)
CTNNA2.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
31 31
32 32
33
-[[include:browser_CTNNA2.md]]
33
+[[include:tables/browser_CTNNA2.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/CTNNA2_by_pathology.svg)
CTSS.md
... ...
@@ -36,7 +36,7 @@ Driver mutations affecting this gene in FL have been experimentally demonstrated
36 36
| chr1 | 150727482 | A>C | Y132D |
37 37
| chr1 | 150727482 | A>T | Y132N |
38 38
39
-[[include:browser_CTSS.md]]
39
+[[include:tables/browser_CTSS.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/CTSS_by_pathology.svg)
CXCR4.md
... ...
@@ -43,7 +43,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
43 43
44 44
45 45
46
-[[include:browser_CXCR4.md]]
46
+[[include:tables/browser_CXCR4.md]]
47 47
48 48
## Expression
49 49
![](images/gene_expression/CXCR4_by_pathology.svg)
CXCR5.md
... ...
@@ -37,7 +37,7 @@ CXCR5 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)
37 37
38 38
39 39
40
-[[include:browser_CXCR5.md]]
40
+[[include:tables/browser_CXCR5.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/CXCR5_by_pathology.svg)
CYB5D1.md
... ...
@@ -34,7 +34,7 @@ nocite: |
34 34
35 35
36 36
37
-[[include:browser_CYB5D1.md]]
37
+[[include:tables/browser_CYB5D1.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/CYB5D1_by_pathology.svg)
CYP2A6.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
27 27
28 28
29
-[[include:browser_CYP2A6.md]]
29
+[[include:tables/browser_CYP2A6.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/CYP2A6_by_pathology.svg)
CYP4F22.md
... ...
@@ -34,7 +34,7 @@ Due to [minimal support](CYP4F22#representative-mutation) in the original primar
34 34
[[include:tables/dnds_CYP4F22.md]]
35 35
36 36
37
-[[include:browser_CYP4F22.md]]
37
+[[include:tables/browser_CYP4F22.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/CYP4F22_by_pathology.svg)
DAZAP1.md
... ...
@@ -38,7 +38,7 @@ This gene has some recurrent sites of mutations (hot spots). The mutation patter
38 38
| chr19 | 1434903 | C>T | R406* |
39 39
| chr19 | 1434906 | C>T | R407C |
40 40
41
-[[include:browser_DAZAP1.md]]
41
+[[include:tables/browser_DAZAP1.md]]
42 42
43 43
## Expression
44 44
![](images/gene_expression/DAZAP1_by_pathology.svg)
DCAF6.md
... ...
@@ -36,7 +36,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re
36 36
37 37
38 38
39
-[[include:browser_DCAF6.md]]
39
+[[include:tables/browser_DCAF6.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/DCAF6_by_pathology.svg)
DDX10.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_DDX10.md]]
32
+[[include:tables/browser_DDX10.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/DDX10_by_pathology.svg)
DDX3X.md
... ...
@@ -43,7 +43,7 @@ Driver mutations affecting this gene in DLBCL/BL have been experimentally demons
43 43
44 44
45 45
46
-[[include:browser_DDX3X.md]]
46
+[[include:tables/browser_DDX3X.md]]
47 47
48 48
## Expression
49 49
![](images/gene_expression/DDX3X_by_pathology.svg)
DHDH.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
31 31
32 32
33
-[[include:browser_DHDH.md]]
33
+[[include:tables/browser_DHDH.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/DHDH_by_pathology.svg)
DHX15.md
... ...
@@ -29,7 +29,7 @@ Mutations in this gene were first described in FL in 2021 by Hübschmann et al.[
29 29
30 30
31 31
32
-[[include:browser_DHX15.md]]
32
+[[include:tables/browser_DHX15.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/DHX15_by_pathology.svg)
DHX16.md
... ...
@@ -32,7 +32,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a
32 32
33 33
34 34
35
-[[include:browser_DHX16.md]]
35
+[[include:tables/browser_DHX16.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/DHX16_by_pathology.svg)
DICER1.md
... ...
@@ -35,7 +35,7 @@ Mutations in this gene were reported to be inflated in the original results acco
35 35
36 36
37 37
38
-[[include:browser_DICER1.md]]
38
+[[include:tables/browser_DICER1.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/DICER1_by_pathology.svg)
DLC1.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_DLC1.md]]
32
+[[include:tables/browser_DLC1.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/DLC1_by_pathology.svg)
DLGAP1.md
... ...
@@ -35,7 +35,7 @@ Due to [minimal support](DLGAP1#representative-mutation) in the original primary
35 35
36 36
37 37
38
-[[include:browser_DLGAP1.md]]
38
+[[include:tables/browser_DLGAP1.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/DLGAP1_by_pathology.svg)
DNAH5.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_DNAH5.md]]
31
+[[include:tables/browser_DNAH5.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/DNAH5_by_pathology.svg)
DNM2.md
... ...
@@ -36,7 +36,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma
36 36
| :---:| :---: | :--: | :---: |
37 37
| chr19 | 10934492 | G>A | E604K |
38 38
39
-[[include:browser_DNM2.md]]
39
+[[include:tables/browser_DNM2.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/DNM2_by_pathology.svg)
DNMT1.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
32 32
33 33
34
-[[include:browser_DNMT1.md]]
34
+[[include:tables/browser_DNMT1.md]]
35 35
36 36
## Expression
37 37
DNMT3A.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
36 36
37 37
38
-[[include:browser_DNMT3A.md]]
38
+[[include:tables/browser_DNMT3A.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/DNMT3A_by_pathology.svg)
DOCK1.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_DOCK1.md]]
32
+[[include:tables/browser_DOCK1.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/DOCK1_by_pathology.svg)
DSG4.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_DSG4.md]]
32
+[[include:tables/browser_DSG4.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/DSG4_by_pathology.svg)
DTX1.md
... ...
@@ -84,7 +84,7 @@ Mutations in the DTX1 gene, which encodes the E3 ubiquitin ligase Deltex 1, have
84 84
| chr12 | 113496212 | A>G | Y72C |
85 85
| chr12 | 113496213 | C>A | Y72* |
86 86
87
-[[include:browser_DTX1.md]]
87
+[[include:tables/browser_DTX1.md]]
88 88
89 89
## Expression
90 90
![](images/gene_expression/DTX1_by_pathology.svg)
DUSP2.md
... ...
@@ -56,7 +56,7 @@ The mutation pattern in DLBCL implies the preferential accumulation of *inactiva
56 56
| chr2 | 96810582 | C>T | C143Y |
57 57
| chr2 | 96810574 | C>T | A146T |
58 58
59
-[[include:browser_DUSP2.md]]
59
+[[include:tables/browser_DUSP2.md]]
60 60
61 61
## Expression
62 62
![](images/gene_expression/DUSP2_by_pathology.svg)
E2F2.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_E2F2.md]]
31
+[[include:tables/browser_E2F2.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/E2F2_by_pathology.svg)
EBF1.md
... ...
@@ -57,7 +57,7 @@ Driver mutations affecting this gene in DLBCL/FL have been experimentally demons
57 57
| chr5 | 158500468 | A>G | C164R |
58 58
| chr5 | 158500467 | C>G | C164S |
59 59
60
-[[include:browser_EBF1.md]]
60
+[[include:tables/browser_EBF1.md]]
61 61
62 62
## Expression
63 63
![](images/gene_expression/EBF1_by_pathology.svg)
EDNRB.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_EDNRB.md]]
31
+[[include:tables/browser_EDNRB.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/EDNRB_by_pathology.svg)
EEF1A1.md
... ...
@@ -43,7 +43,7 @@ This gene has some recurrent sites of mutations (hot spots). The mutation patter
43 43
| chr6 | 74229095 | C>T | D97N |
44 44
45 45
46
-[[include:browser_EEF1A1.md]]
46
+[[include:tables/browser_EEF1A1.md]]
47 47
48 48
## Expression
49 49
## EEF1A1 Expression
EHD1.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
27 27
28
-[[include:browser_EHD1.md]]
28
+[[include:tables/browser_EHD1.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/EHD1_by_pathology.svg)
EIF2AK3.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
27 27
28 28
29
-[[include:browser_EIF2AK3.md]]
29
+[[include:tables/browser_EIF2AK3.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/EIF2AK3_by_pathology.svg)
EIF2AK4.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
|FL |No |No |0.000 |0 |
29 29
30 30
31
-[[include:browser_EIF2AK4.md]]
31
+[[include:tables/browser_EIF2AK4.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/EIF2AK4_by_pathology.svg)
EIF2C4.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
### DLBCL
31 31
[[include:tables/DLBCL_EIF2C4.md]]
32 32
33
-[[include:browser_EIF2C4.md]]
33
+[[include:tables/browser_EIF2C4.md]]
34 34
35 35
[[include:tables/mermaid_EIF2C4.md]]
36 36
EIF4A1.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
[[include:tables/dnds_EIF4A1.md]]
27 27
28 28
29
-[[include:browser_EIF4A1.md]]
29
+[[include:tables/browser_EIF4A1.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/EIF4A1_by_pathology.svg)
EML2.md
... ...
@@ -36,7 +36,7 @@ Due to [minimal support](EML2#representative-mutation) in the original primary d
36 36
[[include:tables/dnds_EML2.md]]
37 37
38 38
39
-[[include:browser_EML2.md]]
39
+[[include:tables/browser_EML2.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/EML2_by_pathology.svg)
ENTPD3.md
... ...
@@ -34,7 +34,7 @@ nocite: |
34 34
35 35
36 36
37
-[[include:browser_ENTPD3.md]]
37
+[[include:tables/browser_ENTPD3.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/ENTPD3_by_pathology.svg)
EP300.md
... ...
@@ -63,7 +63,7 @@ Studies using genome-wide CRISPR-Cas9 screens have identified synthetic lethal i
63 63
|chr22| 41566523 | A>G | Y1467C |
64 64
|chr22| 41566523 | A>T | Y1467F |
65 65
66
-[[include:browser_EP300.md]]
66
+[[include:tables/browser_EP300.md]]
67 67
68 68
## Expression
69 69
![](images/gene_expression/EP300_by_pathology.svg)
EPHB2.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_EPHB2.md]]
36
+[[include:tables/browser_EPHB2.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/EPHB2_by_pathology.svg)
EPPK1.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
| :---:| :---: | :--: | :---: |
33 33
| chr8 | 144946005 | G>A | R473W |
34 34
35
-[[include:browser_EPPK1.md]]
35
+[[include:tables/browser_EPPK1.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/EPPK1_by_pathology.svg)
ERAP1.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_ERAP1.md]]
31
+[[include:tables/browser_ERAP1.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/ERAP1_by_pathology.svg)
ESX1.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
31 31
32 32
33
-[[include:browser_ESX1.md]]
33
+[[include:tables/browser_ESX1.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/ESX1_by_pathology.svg)
ETS1.md
... ...
@@ -67,7 +67,7 @@ The mutation pattern in DLBCL implies the preferential accumulation of *inactiva
67 67
| chr11 | 128391824 | C>G | E22D |
68 68
| chr11 | 128391823 | G>A | L23F |
69 69
70
-[[include:browser_ETS1.md]]
70
+[[include:tables/browser_ETS1.md]]
71 71
72 72
## Expression
73 73
![](images/gene_expression/ETS1_by_pathology.svg)
ETV6.md
... ...
@@ -49,7 +49,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
49 49
| chr12 | 11803087 | G>A | S9N |
50 50
| chr12 | 11803094 | G>A | K11= |
51 51
52
-[[include:browser_ETV6.md]]
52
+[[include:tables/browser_ETV6.md]]
53 53
54 54
## Expression
55 55
![](images/gene_expression/ETV6_by_pathology.svg)
EWSR1.md
... ...
@@ -21,7 +21,7 @@ nocite: |
21 21
## Mutation pattern and selective pressure estimates
22 22
-->
23 23
24
-[[include:browser_EWSR1.md]]
24
+[[include:tables/browser_EWSR1.md]]
25 25
26 26
## Expression
27 27
![](images/gene_expression/EWSR1_by_pathology.svg)
EXOSC6.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_EXOSC6.md]]
30
+[[include:tables/browser_EXOSC6.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/EXOSC6_by_pathology.svg)
EZH2.md
... ...
@@ -58,7 +58,7 @@ Combination therapies including EZH2 inhibitors are also under exploration for D
58 58
|chr7|148506437|GC>AA|A692L|
59 59
|chr7|148506437|G>A|A692V|
60 60
61
-[[include:browser_EZH2.md]]
61
+[[include:tables/browser_EZH2.md]]
62 62
63 63
## Expression
64 64
![](images/gene_expression/EZH2_by_pathology.svg)
EZR.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
|chr6 |159237903 |159240216|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr6%3A159237903%2D159240216)|NA |
38 38
39 39
40
-[[include:browser_EZR.md]]
40
+[[include:tables/browser_EZR.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/EZR_by_pathology.svg)
FAM102A.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
|chr9 |130740362 |130744800|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr9%3A130740362%2D130744800)|NA |
38 38
39 39
40
-[[include:browser_FAM102A.md]]
40
+[[include:tables/browser_FAM102A.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/FAM102A_by_pathology.svg)
FAM129B.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
32 32
[[include:tables/dnds_FAM129B.md]]
33 33
34
-[[include:browser_FAM129B.md]]
34
+[[include:tables/browser_FAM129B.md]]
35 35
36 36
## Representative Mutations
37 37
FANK1.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
|chr10 |127578912 |127591133|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr10%3A127578912%2D127591133)|active_promoter |
38 38
39 39
40
-[[include:browser_FANK1.md]]
40
+[[include:tables/browser_FANK1.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/FANK1_by_pathology.svg)
FAS.md
... ...
@@ -35,7 +35,7 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons
35 35
36 36
[[include:tables/dnds_FAS.md]]
37 37
38
-[[include:browser_FAS.md]]
38
+[[include:tables/browser_FAS.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/FAS_by_pathology.svg)
FAT4.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_FAT4.md]]
32
+[[include:tables/browser_FAT4.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/FAT4_by_pathology.svg)
FBXO11.md
... ...
@@ -53,7 +53,7 @@ Driver mutations affecting this gene in DLBCL/BL have been experimentally demons
53 53
|chr2|48040511|C>G|G697R|
54 54
55 55
56
-[[include:browser_FBXO11.md]]
56
+[[include:tables/browser_FBXO11.md]]
57 57
58 58
## Expression
59 59
![](images/gene_expression/FBXO11_by_pathology.svg)
FBXW7.md
... ...
@@ -33,7 +33,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
33 33
34 34
35 35
36
-[[include:browser_FBXW7.md]]
36
+[[include:tables/browser_FBXW7.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/FBXW7_by_pathology.svg)
FCRL3.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
|chr2 |157669490 |157671299|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr2%3A157669490%2D157671299)|NA |
38 38
39 39
40
-[[include:browser_FCRL3.md]]
40
+[[include:tables/browser_FCRL3.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/FCRL3_by_pathology.svg)
FGFR3.md
... ...
@@ -37,7 +37,7 @@ Due to [minimal support](FGFR3#representative-mutation) in the original primary
37 37
38 38
39 39
40
-[[include:browser_FGFR3.md]]
40
+[[include:tables/browser_FGFR3.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/FGFR3_by_pathology.svg)
FLYWCH1.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_FLYWCH1.md]]
30
+[[include:tables/browser_FLYWCH1.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/FLYWCH1_by_pathology.svg)
FNBP1.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
|chr9 |132800698 |132805491|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr9%3A132800698%2D132805491)|NA |
38 38
39 39
40
-[[include:browser_FNBP1.md]]
40
+[[include:tables/browser_FNBP1.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/FNBP1_by_pathology.svg)
FNDC1.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_FNDC1.md]]
31
+[[include:tables/browser_FNDC1.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/FNDC1_by_pathology.svg)
FOXC1.md
... ...
@@ -29,7 +29,7 @@ FOXC1 is a transcription factor that regulates genes involved in cell growth, di
29 29
30 30
31 31
32
-[[include:browser_FOXC1.md]]
32
+[[include:tables/browser_FOXC1.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/FOXC1_by_pathology.svg)
FOXO1.md
... ...
@@ -60,7 +60,7 @@ Driver mutations affecting this gene in FL/DLBCL/BL have been experimentally dem
60 60
| chr13 | 41240273 | G>A | P26L |
61 61
| chr13 | 41240271 | G>C | L27V |
62 62
63
-[[include:browser_FOXO1.md]]
63
+[[include:tables/browser_FOXO1.md]]
64 64
65 65
## Expression
66 66
![](images/gene_expression/FOXO1_by_pathology.svg)
FOXP1.md
... ...
@@ -38,7 +38,7 @@ nocite: |
38 38
|chr3 |71626341 |71635648|[TSS-1](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr3%3A71626341%2D71635648) |active_promoter |
39 39
40 40
41
-[[include:browser_FOXP1.md]]
41
+[[include:tables/browser_FOXP1.md]]
42 42
43 43
## Expression
44 44
![](images/gene_expression/FOXP1_by_pathology.svg)
FTCD.md
... ...
@@ -40,7 +40,7 @@ Due to [minimal support](FTCD#representative-mutation) in the original primary d
40 40
41 41
42 42
43
-[[include:browser_FTCD.md]]
43
+[[include:tables/browser_FTCD.md]]
44 44
45 45
## Expression
46 46
![](images/gene_expression/FTCD_by_pathology.svg)
FUBP1.md
... ...
@@ -34,7 +34,7 @@ nocite: |
34 34
| :---:| :---: | :--: | :---: |
35 35
| chr1 | 78444687 | A>C | M1? |
36 36
37
-[[include:browser_FUBP1.md]]
37
+[[include:tables/browser_FUBP1.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/FUBP1_by_pathology.svg)
FUT5.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_FUT5.md]]
31
+[[include:tables/browser_FUT5.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/FUT5_by_pathology.svg)
FZD3.md
... ...
@@ -34,7 +34,7 @@ nocite: |
34 34
35 35
36 36
37
-[[include:browser_FZD3.md]]
37
+[[include:tables/browser_FZD3.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/FZD3_by_pathology.svg)
FZR1.md
... ...
@@ -26,7 +26,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma
26 26
27 27
[[include:tables/dnds_FZR1.md]]
28 28
29
-[[include:browser_FZR1.md]]
29
+[[include:tables/browser_FZR1.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/FZR1_by_pathology.svg)
GABRA2.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_GABRA2.md]]
31
+[[include:tables/browser_GABRA2.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/GABRA2_by_pathology.svg)
GAK.md
... ...
@@ -29,7 +29,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a
29 29
30 30
[[include:tables/dnds_GAK.md]]
31 31
32
-[[include:browser_GAK.md]]
32
+[[include:tables/browser_GAK.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/GAK_by_pathology.svg)
GBP7.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
27 27
28
-[[include:browser_GBP7.md]]
28
+[[include:tables/browser_GBP7.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/GBP7_by_pathology.svg)
GGTLA4.md
... ...
@@ -17,7 +17,7 @@ nocite: |
17 17
18 18
[[include:tables/BL_GGTLA4.md]]
19 19
20
-[[include:browser_GGTLA4.md]]
20
+[[include:tables/browser_GGTLA4.md]]
21 21
22 22
## Representative Mutations
23 23
GNA13.md
... ...
@@ -45,7 +45,7 @@ Driver mutations affecting this gene in BL/FL/DLBCL have been experimentally dem
45 45
| chr17 | 63052613 | C>G | E33D |
46 46
| chr17 | 63052609 | C>G | D35H |
47 47
48
-[[include:browser_GNA13.md]]
48
+[[include:tables/browser_GNA13.md]]
49 49
50 50
## Expression
51 51
![](images/gene_expression/GNA13_by_pathology.svg)
GNAI2.md
... ...
@@ -52,7 +52,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
52 52
| chr3 | 50293698 | T>A | V180E |
53 53
| chr3 | 50293703 | A>G | T182A |
54 54
55
-[[include:browser_GNAI2.md]]
55
+[[include:tables/browser_GNAI2.md]]
56 56
57 57
## Expression
58 58
![](images/gene_expression/GNAI2_by_pathology.svg)
GNAS.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_GNAS.md]]
36
+[[include:tables/browser_GNAS.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/GNAS_by_pathology.svg)
GOLGA5.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_GOLGA5.md]]
31
+[[include:tables/browser_GOLGA5.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/GOLGA5_by_pathology.svg)
GPC5.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_GPC5.md]]
31
+[[include:tables/browser_GPC5.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/GPC5_by_pathology.svg)
GRB2.md
... ...
@@ -27,7 +27,7 @@ Further research is needed to elucidate its specific role in DLBCL.
27 27
28 28
[[include:tables/dnds_GRB2.md]]
29 29
30
-[[include:browser_GRB2.md]]
30
+[[include:tables/browser_GRB2.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/GRB2_by_pathology.svg)
GRHPR.md
... ...
@@ -32,7 +32,7 @@ GRHPR is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)
32 32
33 33
34 34
35
-[[include:browser_GRHPR.md]]
35
+[[include:tables/browser_GRHPR.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/GRHPR_by_pathology.svg)
GRIK5.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_GRIK5.md]]
35
+[[include:tables/browser_GRIK5.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/GRIK5_by_pathology.svg)
GRIN2A.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_GRIN2A.md]]
32
+[[include:tables/browser_GRIN2A.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/GRIN2A_by_pathology.svg)
GRM6.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
27 27
28
-[[include:browser_GRM6.md]]
28
+[[include:tables/browser_GRM6.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/GRM6_by_pathology.svg)
GSG2.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_GSG2.md]]
35
+[[include:tables/browser_GSG2.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/GSG2_by_pathology.svg)
GTSE1.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_GTSE1.md]]
30
+[[include:tables/browser_GTSE1.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/GTSE1_by_pathology.svg)
HDAC7.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_HDAC7.md]]
31
+[[include:tables/browser_HDAC7.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/HDAC7_by_pathology.svg)
HEPH.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
27 27
28
-[[include:browser_HEPH.md]]
28
+[[include:tables/browser_HEPH.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/HEPH_by_pathology.svg)
HIST1H1B.md
... ...
@@ -30,7 +30,7 @@ This is one of several genes that encode linker histone proteins that are recurr
30 30
31 31
[[include:tables/dnds_HIST1H1B.md]]
32 32
33
-[[include:browser_HIST1H1B.md]]
33
+[[include:tables/browser_HIST1H1B.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/HIST1H1B_by_pathology.svg)
HIST1H1C.md
... ...
@@ -41,7 +41,7 @@ Mutations are often found in the globular domain of the protein, which is critic
41 41
[[include:tables/dnds_HIST1H1C.md]]
42 42
43 43
44
-[[include:browser_HIST1H1C.md]]
44
+[[include:tables/browser_HIST1H1C.md]]
45 45
46 46
[[include:tables/mermaid_HIST1H1C.md]]
47 47
HIST1H1D.md
... ...
@@ -34,7 +34,7 @@ Mutations are often found in the globular domain of the protein, which is critic
34 34
35 35
36 36
37
-[[include:browser_HIST1H1D.md]]
37
+[[include:tables/browser_HIST1H1D.md]]
38 38
39 39
40 40
[[include:tables/mermaid_HIST1H1D.md]]
HIST1H1E.md
... ...
@@ -57,7 +57,7 @@ Mutations in this gene were first described in DLBCL in 2013 by Morin et al.[@mo
57 57
| chr6 | 26157121 | A>T | K168I |
58 58
| chr6 | 26157139 | A>G | K174R |
59 59
60
-[[include:browser_HIST1H1E.md]]
60
+[[include:tables/browser_HIST1H1E.md]]
61 61
62 62
[[include:tables/mermaid_HIST1H1E.md]]
63 63
HIST1H2AC.md
... ...
@@ -56,7 +56,7 @@ This gene encodes the H2A protein, one of the core proteins comprising nucleosom
56 56
| chr6 | 26124819 | A>G | K120R |
57 57
| chr6 | 26124832 | CC>TT | H125Y |
58 58
59
-[[include:browser_HIST1H2AC.md]]
59
+[[include:tables/browser_HIST1H2AC.md]]
60 60
61 61
## Expression
62 62
![](images/gene_expression/HIST1H2AC_by_pathology.svg)
HIST1H2AG.md
... ...
@@ -44,7 +44,7 @@ nocite: |
44 44
| chr6 | 27101126 | G>T | E92D |
45 45
| chr6 | 27101130 | C>G | L94V |
46 46
47
-[[include:browser_HIST1H2AG.md]]
47
+[[include:tables/browser_HIST1H2AG.md]]
48 48
49 49
[[include:tables/mermaid_HIST1H2AG.md]]
50 50
HIST1H2AM.md
... ...
@@ -72,7 +72,7 @@ This gene encodes the H2A protein, one of the core proteins comprising nucleosom
72 72
| chr6 | 27860542 | C>T | G129D |
73 73
| chr6 | 27860538 | C>G | K130N |
74 74
75
-[[include:browser_HIST1H2AM.md]]
75
+[[include:tables/browser_HIST1H2AM.md]]
76 76
77 77
78 78
[[include:tables/mermaid_HIST1H2AM.md]]
HIST1H2BC.md
... ...
@@ -60,7 +60,7 @@ This gene encodes the H2A protein, one of the core proteins comprising nucleosom
60 60
| chr6 | 26123881 | G>C | Y84* |
61 61
| chr6 | 26123874 | G>A | R87C |
62 62
63
-[[include:browser_HIST1H2BC.md]]
63
+[[include:tables/browser_HIST1H2BC.md]]
64 64
65 65
## Expression
66 66
![](images/gene_expression/HIST1H2BC_by_pathology.svg)
HIST1H2BD.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_HIST1H2BD.md]]
31
+[[include:tables/browser_HIST1H2BD.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/HIST1H2BD_by_pathology.svg)
HIST1H2BG.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_HIST1H2BG.md]]
31
+[[include:tables/browser_HIST1H2BG.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/HIST1H2BG_by_pathology.svg)
HIST1H2BK.md
... ...
@@ -39,7 +39,7 @@ This gene encodes the H2A protein, one of the core proteins comprising nucleosom
39 39
40 40
41 41
42
-[[include:browser_HIST1H2BK.md]]
42
+[[include:tables/browser_HIST1H2BK.md]]
43 43
44 44
[[include:tables/mermaid_HIST1H2BK.md]]
45 45
HIST1H2BM.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_HIST1H2BM.md]]
32
+[[include:tables/browser_HIST1H2BM.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/HIST1H2BM_by_pathology.svg)
HIST1H3B.md
... ...
@@ -41,7 +41,7 @@ nocite: |
41 41
|chr6|26032017|A>G|M91T|
42 42
43 43
44
-[[include:browser_HIST1H3B.md]]
44
+[[include:tables/browser_HIST1H3B.md]]
45 45
46 46
[[include:tables/mermaid_HIST1H3B.md]]
47 47
HIST1H3D.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
| chr6 | 26197219 | C>G | S87T |
30 30
| chr6 | 26197219 | C>T | S87N |
31 31
32
-[[include:browser_HIST1H3D.md]]
32
+[[include:tables/browser_HIST1H3D.md]]
33 33
34 34
[[include:tables/mermaid_HIST1H3D.md]]
35 35
HIST1H3G.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_HIST1H3G.md]]
31
+[[include:tables/browser_HIST1H3G.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/HIST1H3G_by_pathology.svg)
HIST1H3H.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
[[include:tables/dnds_HIST1H3H]]
28 28
29 29
30
-[[include:browser_HIST1H3H.md]]
30
+[[include:tables/browser_HIST1H3H.md]]
31 31
32 32
[[include:tables/mermaid_HIST1H3H.md]]
33 33
HIST1H3I.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
[[include:tables/dnds_HIST1H3I]]
29 29
30 30
31
-[[include:browser_HIST1H3I.md]]
31
+[[include:tables/browser_HIST1H3I.md]]
32 32
33 33
34 34
[[include:tables/mermaid_HIST1H3I.md]]
HIST1H3J.md
... ...
@@ -36,7 +36,7 @@ nocite: |
36 36
| chr6 | 27858222 | G>A | R117C |
37 37
| chr6 | 27858210 | T>G | M121L |
38 38
39
-[[include:browser_HIST1H3J.md]]
39
+[[include:tables/browser_HIST1H3J.md]]
40 40
41 41
[[include:tables/mermaid_HIST1H3J.md]]
42 42
HIST1H4J.md
... ...
@@ -21,7 +21,7 @@ nocite: |
21 21
22 22
[[include:tables/dnds_HIST1H4J]]
23 23
24
-[[include:browser_HIST1H4J.md]]
24
+[[include:tables/browser_HIST1H4J.md]]
25 25
26 26
## Representative Mutations
27 27
HIST2H2BE.md
... ...
@@ -27,7 +27,7 @@ This gene encodes the H2A protein, one of the core proteins comprising nucleosom
27 27
[[include:tables/dnds_HIST2H2BE.md]]
28 28
29 29
30
-[[include:browser_HIST2H2BE.md]]
30
+[[include:tables/browser_HIST2H2BE.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/HIST2H2BE_by_pathology.svg)
HLA-A.md
... ...
@@ -43,7 +43,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
43 43
| chr6 | 29910596 | T>A | F46I |
44 44
| chr6 | 29910609 | G>A | G50D |
45 45
46
-[[include:browser_HLA-A.md]]
46
+[[include:tables/browser_HLA-A.md]]
47 47
48 48
## Expression
49 49
![](images/gene_expression/HLA-A_by_pathology.svg)
HLA-B.md
... ...
@@ -44,7 +44,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
44 44
| chr6 | 31324583 | C>G | W75C |
45 45
| chr6 | 31324576 | G>A | Q78* |
46 46
47
-[[include:browser_HLA-B.md]]
47
+[[include:tables/browser_HLA-B.md]]
48 48
49 49
## Expression
50 50
![](images/gene_expression/HLA-B_by_pathology.svg)
HLA-C.md
... ...
@@ -30,7 +30,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
30 30
31 31
[[include:tables/dnds_HLA-C.md]]
32 32
33
-[[include:browser_HLA-C.md]]
33
+[[include:tables/browser_HLA-C.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/HLA-C_by_pathology.svg)
HLA-DMA.md
... ...
@@ -29,7 +29,7 @@ Mutations in this gene are relatively rare in DLBCL overall.
29 29
30 30
31 31
32
-[[include:browser_HLA-DMA.md]]
32
+[[include:tables/browser_HLA-DMA.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/HLA-DMA_by_pathology.svg)
HLA-DMB.md
... ...
@@ -26,7 +26,7 @@ Mutations in this gene were first described in DLBCL by [Hübschmann et al](pape
26 26
27 27
[[include:tables/dnds_HLA-DMB.md]]
28 28
29
-[[include:browser_HLA-DMB.md]]
29
+[[include:tables/browser_HLA-DMB.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/HLA-DMB_by_pathology.svg)
HLA-DQB1.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_HLA-DQB1.md]]
30
+[[include:tables/browser_HLA-DQB1.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/HLA-DQB1_by_pathology.svg)
HNF1B.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_HNF1B.md]]
31
+[[include:tables/browser_HNF1B.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/HNF1B_by_pathology.svg)
HNRNPH1.md
... ...
@@ -37,7 +37,7 @@ The common HNRNPH1 mutations cause deregulated splicing and increased expression
37 37
| :---:| :---: | :--: | :---: |
38 38
| chr5 | 179046407 | C>A | G133= |
39 39
40
-[[include:browser_HNRNPH1.md]]
40
+[[include:tables/browser_HNRNPH1.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/HNRNPH1_by_pathology.svg)
HNRNPU.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
|:--------:|:----------:|:---------:|:-------------------------------------------------------------------------------------------:|:------------------:|
36 36
|chr1 |245023502 |245029083|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr1%3A245023502%2D245029083)|NA |
37 37
38
-[[include:browser_HNRNPU.md]]
38
+[[include:tables/browser_HNRNPU.md]]
39 39
40 40
[[include:tables/mermaid_HNRNPU.md]]
41 41
HRAS.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_HRAS.md]]
36
+[[include:tables/browser_HRAS.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/HRAS_by_pathology.svg)
HVCN1.md
... ...
@@ -36,7 +36,7 @@ HVCN1, a voltage-gated proton channel, has been identified as recurrently mutate
36 36
| chr12 | 111099150 | T>C | Y42C |
37 37
| chr12 | 111099142 | A>T | W45R |
38 38
39
-[[include:browser_HVCN1.md]]
39
+[[include:tables/browser_HVCN1.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/HVCN1_by_pathology.svg)
ICK.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_ICK.md]]
36
+[[include:tables/browser_ICK.md]]
37 37
38 38
39 39
<!-- ORIGIN: loveGeneticLandscapeMutations2012 -->
ID3.md
... ...
@@ -35,7 +35,7 @@ The existence of mutations in DLBCL were described in 2012 by Schmitz et al[@sch
35 35
|:--------:|:----------:|:--------:|:-----------------------------------------------------------------------------------------:|:------------------:|
36 36
|chr1 |23885584 |23885835|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr1%3A23885584%2D23885835)|NA |
37 37
38
-[[include:browser_ID3.md]]
38
+[[include:tables/browser_ID3.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/ID3_by_pathology.svg)
IFNGR1.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_IFNGR1.md]]
31
+[[include:tables/browser_IFNGR1.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/IFNGR1_by_pathology.svg)
IGLL5.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
31 31
32 32
33
-[[include:browser_IGLL5.md]]
33
+[[include:tables/browser_IGLL5.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/IGLL5_by_pathology.svg)
IKBKB.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_IKBKB.md]]
31
+[[include:tables/browser_IKBKB.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/IKBKB_by_pathology.svg)
IKBKE.md
... ...
@@ -31,7 +31,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma
31 31
32 32
33 33
34
-[[include:browser_IKBKE.md]]
34
+[[include:tables/browser_IKBKE.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/IKBKE_by_pathology.svg)
IKZF3.md
... ...
@@ -61,7 +61,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
61 61
|chr17|37944556|C>T|E222K|
62 62
63 63
64
-[[include:browser_IKZF3.md]]
64
+[[include:tables/browser_IKZF3.md]]
65 65
66 66
## Expression
67 67
![](images/gene_expression/IKZF3_by_pathology.svg)
IL16.md
... ...
@@ -29,7 +29,7 @@ The IL16 gene, which encodes a pro-inflammatory cytokine, plays a role in immune
29 29
30 30
31 31
32
-[[include:browser_IL16.md]]
32
+[[include:tables/browser_IL16.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/IL16_by_pathology.svg)
IL4R.md
... ...
@@ -42,7 +42,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
42 42
| :---:| :---: | :--: | :---: |
43 43
| chr16 | 27367183 | T>A | I242N |
44 44
45
-[[include:browser_IL4R.md]]
45
+[[include:tables/browser_IL4R.md]]
46 46
47 47
## Expression
48 48
![](images/gene_expression/IL4R_by_pathology.svg)
IL6.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_IL6.md]]
31
+[[include:tables/browser_IL6.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/IL6_by_pathology.svg)
INO80.md
... ...
@@ -32,7 +32,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero
32 32
33 33
34 34
35
-[[include:browser_INO80.md]]
35
+[[include:tables/browser_INO80.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/INO80_by_pathology.svg)
IRF1.md
... ...
@@ -36,7 +36,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma
36 36
|chr5 |131823933 |131826458|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr5%3A131823933%2D131826458)|active_promoter |
37 37
38 38
39
-[[include:browser_IRF1.md]]
39
+[[include:tables/browser_IRF1.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/IRF1_by_pathology.svg)
IRF4.md
... ...
@@ -47,7 +47,7 @@ There are a few mutation hotspots in this gene. The functional role of mutations
47 47
| chr6 | 393360 | C>G | L70V |
48 48
| chr6 | 393360 | C>T | L70F |
49 49
50
-[[include:browser_IRF4.md]]
50
+[[include:tables/browser_IRF4.md]]
51 51
52 52
## Expression
53 53
![](images/gene_expression/IRF4_by_pathology.svg)
IRF8.md
... ...
@@ -58,7 +58,7 @@ Driver mutations affecting this gene in DLBCL/FL have been experimentally demons
58 58
| chr16 | 85942671 | T>C | C84R |
59 59
| chr16 | 85942692 | G>A | D91N |
60 60
61
-[[include:browser_IRF8.md]]
61
+[[include:tables/browser_IRF8.md]]
62 62
63 63
## Expression
64 64
![](images/gene_expression/IRF8_by_pathology.svg)
ITPKB.md
... ...
@@ -47,7 +47,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
47 47
| chr1 | 226925148 | G>C | Y4* |
48 48
| chr1 | 226925148 | G>T | Y4* |
49 49
50
-[[include:browser_ITPKB.md]]
50
+[[include:tables/browser_ITPKB.md]]
51 51
52 52
## Expression
53 53
![](images/gene_expression/ITPKB_by_pathology.svg)
ITPR3.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
32 32
33 33
34
-[[include:browser_ITPR3.md]]
34
+[[include:tables/browser_ITPR3.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/ITPR3_by_pathology.svg)
JAK1.md
... ...
@@ -39,7 +39,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero
39 39
| :---:| :---: | :--: | :---: |
40 40
| chr1 | 65301158 | C>A | G1097V |
41 41
42
-[[include:browser_JAK1.md]]
42
+[[include:tables/browser_JAK1.md]]
43 43
44 44
## Expression
45 45
![](images/gene_expression/JAK1_by_pathology.svg)
JAK3.md
... ...
@@ -33,7 +33,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero
33 33
34 34
35 35
36
-[[include:browser_JAK3.md]]
36
+[[include:tables/browser_JAK3.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/JAK3_by_pathology.svg)
JUNB.md
... ...
@@ -36,7 +36,7 @@ Mutations in this gene were reported to be inflated in the original results acco
36 36
37 37
38 38
39
-[[include:browser_JUNB.md]]
39
+[[include:tables/browser_JUNB.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/JUNB_by_pathology.svg)
JUP.md
... ...
@@ -27,7 +27,7 @@ Mutations in this gene were first described in FL in 2021 by Hübschmann et al.[
27 27
[[include:tables/dnds_JUP.md]]
28 28
29 29
30
-[[include:browser_JUP.md]]
30
+[[include:tables/browser_JUP.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/JUP_by_pathology.svg)
KCMF1.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_KCMF1.md]]
31
+[[include:tables/browser_KCMF1.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/KCMF1_by_pathology.svg)
KCNK10.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
36 36
37 37
38
-[[include:browser_KCNK10.md]]
38
+[[include:tables/browser_KCNK10.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/KCNK10_by_pathology.svg)
KIFC3.md
... ...
@@ -35,7 +35,7 @@ Due to [minimal support](KIFC3#representative-mutations) in the original primary
35 35
36 36
37 37
38
-[[include:browser_KIFC3.md]]
38
+[[include:tables/browser_KIFC3.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/KIFC3_by_pathology.svg)
KIR3DL1.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
27 27
28
-[[include:browser_KIR3DL1.md]]
28
+[[include:tables/browser_KIR3DL1.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/KIR3DL1_by_pathology.svg)
KLF2.md
... ...
@@ -51,7 +51,7 @@ Contradictory to this, the mutation pattern in DLBCL implies selective pressure
51 51
| chr19 | 16436775 | G>C | S275T |
52 52
| chr19 | 16436784 | G>A | G278D |
53 53
54
-[[include:browser_KLF2.md]]
54
+[[include:tables/browser_KLF2.md]]
55 55
56 56
## Expression
57 57
![](images/gene_expression/KLF2_by_pathology.svg)
KLHL14.md
... ...
@@ -40,7 +40,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
40 40
| chr18 | 30349902 | A>C | F218C |
41 41
| chr18 | 30349882 | G>C | L225V |
42 42
43
-[[include:browser_KLHL14.md]]
43
+[[include:tables/browser_KLHL14.md]]
44 44
45 45
46 46
<!-- ORIGIN: zhangGeneticHeterogeneityDiffuse2013 -->
KLHL21.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_KLHL21.md]]
36
+[[include:tables/browser_KLHL21.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/KLHL21_by_pathology.svg)
KLHL26.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_KLHL26.md]]
30
+[[include:tables/browser_KLHL26.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/KLHL26_by_pathology.svg)
KLHL6.md
... ...
@@ -65,7 +65,7 @@ Driver mutations affecting this gene in DLBCL/FL have been experimentally demons
65 65
| chr3 | 183273155 | T>A | Y96F |
66 66
| chr3 | 183273153 | A>G | F97L |
67 67
68
-[[include:browser_KLHL6.md]]
68
+[[include:tables/browser_KLHL6.md]]
69 69
70 70
## Expression
71 71
![](images/gene_expression/KLHL6_by_pathology.svg)
KMT2C.md
... ...
@@ -28,7 +28,7 @@ This gene has been reported to be recurrently mutated in DLBCL. The rate of muta
28 28
29 29
[[include:tables/dnds_KMT2C.md]]
30 30
31
-[[include:browser_KMT2C.md]]
31
+[[include:tables/browser_KMT2C.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/KMT2C_by_pathology.svg)
KMT2D.md
... ...
@@ -44,7 +44,7 @@ Driver mutations affecting this gene in BL/DLBCL/FL have been experimentally dem
44 44
45 45
[[include:tables/dnds_KMT2D.md]]
46 46
47
-[[include:browser_KMT2D.md]]
47
+[[include:tables/browser_KMT2D.md]]
48 48
49 49
## Expression
50 50
![](images/gene_expression/KMT2D_by_pathology.svg)
KRAS.md
... ...
@@ -38,7 +38,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
38 38
| chr12 | 25398282 | C>A | G13C |
39 39
| chr12 | 25398281 | C>T | G13D |
40 40
41
-[[include:browser_KRAS.md]]
41
+[[include:tables/browser_KRAS.md]]
42 42
43 43
## Expression
44 44
![](images/gene_expression/KRAS_by_pathology.svg)
LAMA5.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_LAMA5.md]]
31
+[[include:tables/browser_LAMA5.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/LAMA5_by_pathology.svg)
LAPTM5.md
... ...
@@ -37,7 +37,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by [Hübschm
37 37
|chr1 |31229012 |31232011|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr1%3A31229012%2D31232011)|NA |
38 38
39 39
40
-[[include:browser_LAPTM5.md]]
40
+[[include:tables/browser_LAPTM5.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/LAPTM5_by_pathology.svg)
LCOR.md
... ...
@@ -33,7 +33,7 @@ LCOR (Ligand Dependent Nuclear Receptor Corepressor) is involved in the regulati
33 33
34 34
35 35
36
-[[include:browser_LCOR.md]]
36
+[[include:tables/browser_LCOR.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/LCOR_by_pathology.svg)
LIN54.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_LIN54.md]]
36
+[[include:tables/browser_LIN54.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/LIN54_by_pathology.svg)
LPP.md
... ...
@@ -42,7 +42,7 @@ nocite: |
42 42
43 43
44 44
45
-[[include:browser_LPP.md]]
45
+[[include:tables/browser_LPP.md]]
46 46
47 47
## Expression
48 48
![](images/gene_expression/LPP_by_pathology.svg)
LRP12.md
... ...
@@ -33,7 +33,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a
33 33
34 34
35 35
36
-[[include:browser_LRP12.md]]
36
+[[include:tables/browser_LRP12.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/LRP12_by_pathology.svg)
LRRN3.md
... ...
@@ -21,7 +21,7 @@ nocite: |
21 21
22 22
[[include:tables/dnds_LRRN3.md]]
23 23
24
-[[include:browser_LRRN3.md]]
24
+[[include:tables/browser_LRRN3.md]]
25 25
26 26
## Expression
27 27
![](images/gene_expression/LRRN3_by_pathology.svg)
LTB.md
... ...
@@ -37,7 +37,7 @@ LTB (Lymphotoxin Beta) is a member of the tumor necrosis factor (TNF) superfamil
37 37
|chr6 |31548325 |31550717|[intron-1](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr6%3A31548325%2D31550717)|enhancer |
38 38
39 39
40
-[[include:browser_LTB.md]]
40
+[[include:tables/browser_LTB.md]]
41 41
42 42
## Expression
43 43
LYN.md
... ...
@@ -29,7 +29,7 @@ LYN mutations have been reported in DLBCL but the rate is relatively rare in mos
29 29
30 30
31 31
32
-[[include:browser_LYN.md]]
32
+[[include:tables/browser_LYN.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/LYN_by_pathology.svg)
MAGEC1.md
... ...
@@ -34,7 +34,7 @@ nocite: |
34 34
| chrX | 140994066 | G>C | Q292H |
35 35
| chrX | 140994280 | A>G | T364A |
36 36
37
-[[include:browser_MAGEC1.md]]
37
+[[include:tables/browser_MAGEC1.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/MAGEC1_by_pathology.svg)
MAGT1.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_MAGT1.md]]
31
+[[include:tables/browser_MAGT1.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/MAGT1_by_pathology.svg)
MALAT1.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
|chr11 |65265237 |65268359|[ncRNA](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr11%3A65265237%2D65268359)|enhancer |
33 33
34 34
35
-[[include:browser_MALAT1.md]]
35
+[[include:tables/browser_MALAT1.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/MALAT1_by_pathology.svg)
MAP2K1.md
... ...
@@ -35,7 +35,7 @@ Driver mutations affecting this gene in FL have been experimentally demonstrated
35 35
| chr15 | 66727441 | T>C | F53L |
36 36
| chr15 | 66727454 | A>C | K57T |
37 37
38
-[[include:browser_MAP2K1.md]]
38
+[[include:tables/browser_MAP2K1.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/MAP2K1_by_pathology.svg)
MAP3K6.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_MAP3K6.md]]
35
+[[include:tables/browser_MAP3K6.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/MAP3K6_by_pathology.svg)
MAP4K4.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_MAP4K4.md]]
36
+[[include:tables/browser_MAP4K4.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/MAP4K4_by_pathology.svg)
MAP7D1.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
27 27
28
-[[include:browser_MAP7D1.md]]
28
+[[include:tables/browser_MAP7D1.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/MAP7D1_by_pathology.svg)
MARK1.md
... ...
@@ -34,7 +34,7 @@ nocite: |
34 34
35 35
36 36
37
-[[include:browser_MARK1.md]]
37
+[[include:tables/browser_MARK1.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/MARK1_by_pathology.svg)
MCL1.md
... ...
@@ -40,7 +40,7 @@ MCL1 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)
40 40
|chr1 |150550814 |150552135|[intron](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr1%3A150550814%2D150552135)|NA |
41 41
42 42
43
-[[include:browser_MCL1.md]]
43
+[[include:tables/browser_MCL1.md]]
44 44
45 45
## Expression
46 46
![](images/gene_expression/MCL1_by_pathology.svg)
MECOM.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_MECOM.md]]
31
+[[include:tables/browser_MECOM.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/MECOM_by_pathology.svg)
MEF2B.md
... ...
@@ -69,7 +69,7 @@ Mutations in the transcriptional activation domain, like N81, can enhance the ab
69 69
| chr19 | 19260045 | T>A | D83V |
70 70
| chr19 | 19260042 | A>G | I84T |
71 71
72
-[[include:browser_MEF2B.md]]
72
+[[include:tables/browser_MEF2B.md]]
73 73
74 74
## Expression
75 75
![](images/gene_expression/MEF2B_by_pathology.svg)
MEF2C.md
... ...
@@ -39,7 +39,7 @@ Mutations in this gene were first described in DLBCL by [Arthur et al](papers/ar
39 39
|chr5 |88182244 |88206620|[TSS-1](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr5%3A88182244%2D88206620)|active_promoter |
40 40
41 41
42
-[[include:browser_MEF2C.md]]
42
+[[include:tables/browser_MEF2C.md]]
43 43
44 44
## Expression
45 45
![](images/gene_expression/MEF2C_by_pathology.svg)
MET.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_MET.md]]
31
+[[include:tables/browser_MET.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/MET_by_pathology.svg)
MGA.md
... ...
@@ -28,7 +28,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
28 28
29 29
[[include:tables/dnds_MGA.md]]
30 30
31
-[[include:browser_MGA.md]]
31
+[[include:tables/browser_MGA.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/MGA_by_pathology.svg)
MGEA5.md
... ...
@@ -31,7 +31,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma
31 31
|FL |No |No |3.398 |0 |
32 32
33 33
34
-[[include:browser_MGEA5.md]]
34
+[[include:tables/browser_MGEA5.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/MGEA5_by_pathology.svg)
MIR155HG.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
|chr21 |26934372 |26937651|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr21%3A26934372%2D26937651)|active_promoter |
34 34
35 35
36
-[[include:browser_MIR155HG.md]]
36
+[[include:tables/browser_MIR155HG.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/MIR155HG_by_pathology.svg)
MKI67.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_MKI67.md]]
31
+[[include:tables/browser_MKI67.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/MKI67_by_pathology.svg)
MME.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
36 36
37 37
38
-[[include:browser_MME.md]]
38
+[[include:tables/browser_MME.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/MME_by_pathology.svg)
MPDZ.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_MPDZ.md]]
31
+[[include:tables/browser_MPDZ.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/MPDZ_by_pathology.svg)
MPEG1.md
... ...
@@ -24,7 +24,7 @@ Mutations in MPEG1 have been described in DLBCL[@morinMutationalStructuralAnalys
24 24
25 25
[[include:tables/dnds_MPEG1.md]]
26 26
27
-[[include:browser_MPEG1.md]]
27
+[[include:tables/browser_MPEG1.md]]
28 28
29 29
## Expression
30 30
![](images/gene_expression/MPEG1_by_pathology.svg)
MRGPRF.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_MRGPRF.md]]
32
+[[include:tables/browser_MRGPRF.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/MRGPRF_by_pathology.svg)
MS4A1.md
... ...
@@ -38,7 +38,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
38 38
|chr11 |60223385 |60225310|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr11%3A60223385%2D60225310)|active_promoter |
39 39
40 40
41
-[[include:browser_MS4A1.md]]
41
+[[include:tables/browser_MS4A1.md]]
42 42
43 43
## Expression
44 44
![](images/gene_expression/MS4A1_by_pathology.svg)
MSH2.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_MSH2.md]]
36
+[[include:tables/browser_MSH2.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/MSH2_by_pathology.svg)
MSH6.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_MSH6.md]]
31
+[[include:tables/browser_MSH6.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/MSH6_by_pathology.svg)
MTOR.md
... ...
@@ -47,7 +47,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
47 47
| :---:| :---: | :--: | :---: |
48 48
| chr1 | 11169376 | A>T | I2500N |
49 49
50
-[[include:browser_MTOR.md]]
50
+[[include:tables/browser_MTOR.md]]
51 51
52 52
## Expression
53 53
![](images/gene_expression/MTOR_by_pathology.svg)
MYB.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_MYB.md]]
36
+[[include:tables/browser_MYB.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/MYB_by_pathology.svg)
MYBPC2.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_MYBPC2.md]]
31
+[[include:tables/browser_MYBPC2.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/MYBPC2_by_pathology.svg)
MYC.md
... ...
@@ -75,7 +75,7 @@ Driver mutations affecting this gene in DLBCL/FL/BL have been experimentally dem
75 75
| chr8 | 128750695 | C>T | P78S |
76 76
| chr8 | 128750696 | C>G | P78R |
77 77
78
-[[include:browser_MYC.md]]
78
+[[include:tables/browser_MYC.md]]
79 79
80 80
## Expression
81 81
MYCBP2.md
... ...
@@ -27,7 +27,7 @@ Mutations in this gene were first described in FL in 2021 by Hübschmann et al.[
27 27
[[include:tables/dnds_MYCBP2.md]]
28 28
29 29
30
-[[include:browser_MYCBP2.md]]
30
+[[include:tables/browser_MYCBP2.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/MYCBP2_by_pathology.svg)
MYD88.md
... ...
@@ -34,7 +34,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
34 34
| :---:| :---: | :--: | :---: |
35 35
| chr3 | 38182641 | T>C | L265P |
36 36
37
-[[include:browser_MYD88.md]]
37
+[[include:tables/browser_MYD88.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/MYD88_by_pathology.svg)
MYH10.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
32 32
33 33
34
-[[include:browser_MYH10.md]]
34
+[[include:tables/browser_MYH10.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/MYH10_by_pathology.svg)
MYO18A.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_MYO18A.md]]
30
+[[include:tables/browser_MYO18A.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/MYO18A_by_pathology.svg)
MYO1E.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
|chr15 |59658991 |59671152|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr15%3A59658991%2D59671152)|NA |
38 38
39 39
40
-[[include:browser_MYO1E.md]]
40
+[[include:tables/browser_MYO1E.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/MYO1E_by_pathology.svg)
MYOM2.md
... ...
@@ -31,7 +31,7 @@ The prevalence of MYOM2 mutations in DLBCL varies across studies. The role of th
31 31
32 32
33 33
34
-[[include:browser_MYOM2.md]]
34
+[[include:tables/browser_MYOM2.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/MYOM2_by_pathology.svg)
NANOG.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_NANOG.md]]
30
+[[include:tables/browser_NANOG.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/NANOG_by_pathology.svg)
NAV1.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_NAV1.md]]
30
+[[include:tables/browser_NAV1.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/NAV1_by_pathology.svg)
NBEAL1.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
27 27
28 28
29
-[[include:browser_NBEAL1.md]]
29
+[[include:tables/browser_NBEAL1.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/NBEAL1_by_pathology.svg)
NCOA3.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
|chr20 |46128611 |46138099|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr20%3A46128611%2D46138099)|active_promoter |
38 38
39 39
40
-[[include:browser_NCOA3.md]]
40
+[[include:tables/browser_NCOA3.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/NCOA3_by_pathology.svg)
NCOR1.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_NCOR1.md]]
36
+[[include:tables/browser_NCOR1.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/NCOR1_by_pathology.svg)
NCOR2.md
... ...
@@ -33,7 +33,7 @@ Mutations in this gene are relatively rare in DLBCL overall but show a pattern o
33 33
34 34
35 35
36
-[[include:browser_NCOR2.md]]
36
+[[include:tables/browser_NCOR2.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/NCOR2_by_pathology.svg)
NEAT1.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
|chr11 |65190369 |65192380|[ncRNA](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr11%3A65190369%2D65192380)|enhancer |
33 33
34 34
35
-[[include:browser_NEAT1.md]]
35
+[[include:tables/browser_NEAT1.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/NEAT1_by_pathology.svg)
NF1.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_NF1.md]]
31
+[[include:tables/browser_NF1.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/NF1_by_pathology.svg)
NFKB1.md
... ...
@@ -44,7 +44,7 @@ Mutations in this gene are relatively rare in DLBCL overall. Some hotspots have
44 44
| chr4 | 103459061 | G>A | G69E |
45 45
| chr4 | 103501730 | G>A | D257N |
46 46
47
-[[include:browser_NFKB1.md]]
47
+[[include:tables/browser_NFKB1.md]]
48 48
49 49
## Expression
50 50
![](images/gene_expression/NFKB1_by_pathology.svg)
NFKB2.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_NFKB2.md]]
36
+[[include:tables/browser_NFKB2.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/NFKB2_by_pathology.svg)
NFKBIA.md
... ...
@@ -31,7 +31,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
31 31
32 32
[[include:tables/dnds_NFKBIA.md]]
33 33
34
-[[include:browser_NFKBIA.md]]
34
+[[include:tables/browser_NFKBIA.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/NFKBIA_by_pathology.svg)
NFKBIE.md
... ...
@@ -32,7 +32,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
32 32
33 33
[[include:tables/dnds_NFKBIE.md]]
34 34
35
-[[include:browser_NFKBIE.md]]
35
+[[include:tables/browser_NFKBIE.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/NFKBIE_by_pathology.svg)
NFKBIZ.md
... ...
@@ -36,7 +36,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
36 36
|chr3 |101568239 |101569274|[TSS-2](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr3%3A101568239%2D101569274)|active_promoter |
37 37
38 38
39
-[[include:browser_NFKBIZ.md]]
39
+[[include:tables/browser_NFKBIZ.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/NFKBIZ_by_pathology.svg)
NIN.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_NIN.md]]
32
+[[include:tables/browser_NIN.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/NIN_by_pathology.svg)
NLRC5.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_NLRC5.md]]
35
+[[include:tables/browser_NLRC5.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/NLRC5_by_pathology.svg)
NLRP5.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_NLRP5.md]]
30
+[[include:tables/browser_NLRP5.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/NLRP5_by_pathology.svg)
NLRP8.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
[[include:tables/dnds_NLRP8.md]]
28 28
29 29
30
-[[include:browser_NLRP8.md]]
30
+[[include:tables/browser_NLRP8.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/NLRP8_by_pathology.svg)
NOA1.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
[[include:tables/dnds_NOA1.md]]
26 26
27 27
28
-[[include:browser_NOA1.md]]
28
+[[include:tables/browser_NOA1.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/NOA1_by_pathology.svg)
NOL9.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
| chr1 | 6614187 | G>C | L126V |
29 29
| chr1 | 6614167 | C>A | Q132H |
30 30
31
-[[include:browser_NOL9.md]]
31
+[[include:tables/browser_NOL9.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/NOL9_by_pathology.svg)
NOTCH1.md
... ...
@@ -48,7 +48,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
48 48
| chr9 | 139401207 | C>T | V1288I |
49 49
| chr9 | 139401199 | G>C | D1290E |
50 50
51
-[[include:browser_NOTCH1.md]]
51
+[[include:tables/browser_NOTCH1.md]]
52 52
53 53
## Expression
54 54
![](images/gene_expression/NOTCH1_by_pathology.svg)
NOTCH2.md
... ...
@@ -36,7 +36,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
36 36
| :---:| :---: | :--: | :---: |
37 37
| chr1 | 120458147 | G>A | R2400* |
38 38
39
-[[include:browser_NOTCH2.md]]
39
+[[include:tables/browser_NOTCH2.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/NOTCH2_by_pathology.svg)
NR2F2.md
... ...
@@ -32,7 +32,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a
32 32
### BL
33 33
[[include:tables/BL_NR2F2.md]]
34 34
35
-[[include:browser_NR2F2.md]]
35
+[[include:tables/browser_NR2F2.md]]
36 36
37 37
## All Mutations
38 38
NRXN2.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
[[include:tables/dnds_NRXN2.md]]
31 31
32 32
33
-[[include:browser_NRXN2.md]]
33
+[[include:tables/browser_NRXN2.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/NRXN2_by_pathology.svg)
NSD2.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_NSD2.md]]
31
+[[include:tables/browser_NSD2.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/NSD2_by_pathology.svg)
OGDHL.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_OGDHL.md]]
31
+[[include:tables/browser_OGDHL.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/OGDHL_by_pathology.svg)
OR8H2.md
... ...
@@ -24,7 +24,7 @@ nocite: |
24 24
25 25
26 26
27
-[[include:browser_OR8H2.md]]
27
+[[include:tables/browser_OR8H2.md]]
28 28
29 29
## Expression
30 30
![](images/gene_expression/OR8H2_by_pathology.svg)
OSBPL10.md
... ...
@@ -31,7 +31,7 @@ OSBPL10 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ash
31 31
|chr3 |32020518 |32024930|[TSS-1](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr3%3A32020518%2D32024930)|active_promoter |
32 32
33 33
34
-[[include:browser_OSBPL10.md]]
34
+[[include:tables/browser_OSBPL10.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/OSBPL10_by_pathology.svg)
P2RX5.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_P2RX5.md]]
36
+[[include:tables/browser_P2RX5.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/P2RX5_by_pathology.svg)
P2RY2.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_P2RY2.md]]
30
+[[include:tables/browser_P2RY2.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/P2RY2_by_pathology.svg)
P2RY8.md
... ...
@@ -33,7 +33,7 @@ Driver mutations affecting this gene in BL/DLBCL have been experimentally demons
33 33
34 34
[[include:tables/dnds_P2RY8.md]]
35 35
36
-[[include:browser_P2RY8.md]]
36
+[[include:tables/browser_P2RY8.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/P2RY8_by_pathology.svg)
PABPC4L.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
36 36
37 37
38
-[[include:browser_PABPC4L.md]]
38
+[[include:tables/browser_PABPC4L.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/PABPC4L_by_pathology.svg)
PAPOLG.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_PAPOLG.md]]
31
+[[include:tables/browser_PAPOLG.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/PAPOLG_by_pathology.svg)
PASK.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_PASK.md]]
31
+[[include:tables/browser_PASK.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/PASK_by_pathology.svg)
PAX5.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
38 38
39 39
40
-[[include:browser_PAX5.md]]
40
+[[include:tables/browser_PAX5.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/PAX5_by_pathology.svg)
PC.md
... ...
@@ -32,7 +32,7 @@ Due to [minimal support](PC#representative-mutations) in the original primary da
32 32
[[include:tables/dnds_PC.md]]
33 33
34 34
35
-[[include:browser_PC.md]]
35
+[[include:tables/browser_PC.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/PC_by_pathology.svg)
PCBP1.md
... ...
@@ -34,7 +34,7 @@ nocite: |
34 34
| chr2 | 70315439 | ->AGCT | S190* |
35 35
| chr2 | 70315457 | C>A | C194* |
36 36
37
-[[include:browser_PCBP1.md]]
37
+[[include:tables/browser_PCBP1.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/PCBP1_by_pathology.svg)
PCDHA11.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
36 36
37 37
38
-[[include:browser_PCDHA11.md]]
38
+[[include:tables/browser_PCDHA11.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/PCDHA11_by_pathology.svg)
PCDHB11.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
[[include:tables/dnds_PCDHB11.md]]
27 27
28 28
29
-[[include:browser_PCDHB11.md]]
29
+[[include:tables/browser_PCDHB11.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/PCDHB11_by_pathology.svg)
PCDHB2.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_PCDHB2.md]]
31
+[[include:tables/browser_PCDHB2.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/PCDHB2_by_pathology.svg)
PCLO.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
| chr7 | 82585302 | A>G | L1656P |
36 36
| chr7 | 82544727 | T>C | K4192R |
37 37
38
-[[include:browser_PCLO.md]]
38
+[[include:tables/browser_PCLO.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/PCLO_by_pathology.svg)
PDCD11.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
27 27
28 28
29
-[[include:browser_PDCD11.md]]
29
+[[include:tables/browser_PDCD11.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/PDCD11_by_pathology.svg)
PDE4DIP.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
[[include:tables/dnds_PDE4DIP.md]]
27 27
28 28
29
-[[include:browser_PDE4DIP.md]]
29
+[[include:tables/browser_PDE4DIP.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/PDE4DIP_by_pathology.svg)
PDS5B.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
[[include:tables/dnds_PDS5B.md]]
30 30
31
-[[include:browser_PDS5B.md]]
31
+[[include:tables/browser_PDS5B.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/PDS5B_by_pathology.svg)
PDZRN3.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
36 36
37 37
38
-[[include:browser_PDZRN3.md]]
38
+[[include:tables/browser_PDZRN3.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/PDZRN3_by_pathology.svg)
PHF6.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
[[include:tables/dnds_PHF6.md]]
27 27
28 28
29
-[[include:browser_PHF6.md]]
29
+[[include:tables/browser_PHF6.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/PHF6_by_pathology.svg)
PIK3CD.md
... ...
@@ -36,7 +36,7 @@ nocite: |
36 36
| chr1 | 9787040 | G>A | R1024H |
37 37
| chr1 | 9787043 | A>G | E1025G |
38 38
39
-[[include:browser_PIK3CD.md]]
39
+[[include:tables/browser_PIK3CD.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/PIK3CD_by_pathology.svg)
PIK3R1.md
... ...
@@ -41,7 +41,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero
41 41
42 42
43 43
44
-[[include:browser_PIK3R1.md]]
44
+[[include:tables/browser_PIK3R1.md]]
45 45
46 46
## Expression
47 47
![](images/gene_expression/PIK3R1_by_pathology.svg)
PIM1.md
... ...
@@ -67,7 +67,7 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons
67 67
| chr6 | 37138603 | GCG>- | G48del |
68 68
| chr6 | 37138604 | C>A | S46R |
69 69
70
-[[include:browser_PIM1.md]]
70
+[[include:tables/browser_PIM1.md]]
71 71
72 72
## Expression
73 73
![](images/gene_expression/PIM1_by_pathology.svg)
PIM2.md
... ...
@@ -32,7 +32,7 @@ PIM2 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)
32 32
|chrX |48774756 |48776255|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chrX%3A48774756%2D48776255)|active_promoter |
33 33
34 34
35
-[[include:browser_PIM2.md]]
35
+[[include:tables/browser_PIM2.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/PIM2_by_pathology.svg)
PKD1.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_PKD1.md]]
30
+[[include:tables/browser_PKD1.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/PKD1_by_pathology.svg)
PLCG2.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
| :---:| :---: | :--: | :---: |
34 34
| chr16 | 81819719 | C>A | T42N |
35 35
36
-[[include:browser_PLCG2.md]]
36
+[[include:tables/browser_PLCG2.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/PLCG2_by_pathology.svg)
PLXNB3.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_PLXNB3.md]]
31
+[[include:tables/browser_PLXNB3.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/PLXNB3_by_pathology.svg)
PNPO.md
... ...
@@ -30,7 +30,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma
30 30
[[include:tables/dnds_PNPO.md]]
31 31
32 32
33
-[[include:browser_PNPO.md]]
33
+[[include:tables/browser_PNPO.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/PNPO_by_pathology.svg)
POGZ.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_POGZ.md]]
30
+[[include:tables/browser_POGZ.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/POGZ_by_pathology.svg)
POLRMT.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
[[include:tables/dnds_POLRMT.md]]
31 31
32 32
33
-[[include:browser_POLRMT.md]]
33
+[[include:tables/browser_POLRMT.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/POLRMT_by_pathology.svg)
POR.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
32 32
33 33
34
-[[include:browser_POR.md]]
34
+[[include:tables/browser_POR.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/POR_by_pathology.svg)
POT1.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
27 27
28
-[[include:browser_POT1.md]]
28
+[[include:tables/browser_POT1.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/POT1_by_pathology.svg)
POU2AF1.md
... ...
@@ -49,7 +49,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
49 49
| chr11 | 111249900 | C>T | M1? |
50 50
| chr11 | 111275352 | T>C | R6G |
51 51
52
-[[include:browser_POU2AF1.md]]
52
+[[include:tables/browser_POU2AF1.md]]
53 53
54 54
## Expression
55 55
![](images/gene_expression/POU2AF1_by_pathology.svg)
POU2F2.md
... ...
@@ -37,7 +37,7 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons
37 37
| chr19 | 42600030 | T>C | T239A |
38 38
| chr19 | 42600030 | T>A | T239S |
39 39
40
-[[include:browser_POU2F2.md]]
40
+[[include:tables/browser_POU2F2.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/POU2F2_by_pathology.svg)
PPP1R9B.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_PPP1R9B.md]]
35
+[[include:tables/browser_PPP1R9B.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/PPP1R9B_by_pathology.svg)
PPP4C.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
| :---:| :---: | :--: | :---: |
30 30
| chr16 | 30093814 | G>A | D54N |
31 31
32
-[[include:browser_PPP4C.md]]
32
+[[include:tables/browser_PPP4C.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/PPP4C_by_pathology.svg)
PPP6R2.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_PPP6R2.md]]
30
+[[include:tables/browser_PPP6R2.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/PPP6R2_by_pathology.svg)
PRDM1.md
... ...
@@ -40,7 +40,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
40 40
| chr6 | 106536324 | G>A | E97= |
41 41
| chr6 | 106536324 | G>C | E97D |
42 42
43
-[[include:browser_PRDM1.md]]
43
+[[include:tables/browser_PRDM1.md]]
44 44
45 45
## Expression
46 46
![](images/gene_expression/PRDM1_by_pathology.svg)
PREX1.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_PREX1.md]]
30
+[[include:tables/browser_PREX1.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/PREX1_by_pathology.svg)
PRKCB.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_PRKCB.md]]
30
+[[include:tables/browser_PRKCB.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/PRKCB_by_pathology.svg)
PRKDC.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_PRKDC.md]]
32
+[[include:tables/browser_PRKDC.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/PRKDC_by_pathology.svg)
PRPS1.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_PRPS1.md]]
31
+[[include:tables/browser_PRPS1.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/PRPS1_by_pathology.svg)
PRSS22.md
... ...
@@ -36,7 +36,7 @@ Due to [minimal support](PRSS22#representative-mutation) in the original primary
36 36
37 37
38 38
39
-[[include:browser_PRSS22.md]]
39
+[[include:tables/browser_PRSS22.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/PRSS22_by_pathology.svg)
PTEN.md
... ...
@@ -28,7 +28,7 @@ Driver mutations affecting this gene in BL/DLBCL have been experimentally demons
28 28
29 29
[[include:tables/dnds_PTEN.md]]
30 30
31
-[[include:browser_PTEN.md]]
31
+[[include:tables/browser_PTEN.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/PTEN_by_pathology.svg)
PTMA.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
|chr2 |232572640 |232574297|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr2%3A232572640%2D232574297)|NA |
38 38
39 39
40
-[[include:browser_PTMA.md]]
40
+[[include:tables/browser_PTMA.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/PTMA_by_pathology.svg)
PTPN1.md
... ...
@@ -36,7 +36,7 @@ nocite: |
36 36
|chr20 |49120482 |49140477|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr20%3A49120482%2D49140477)|active_promoter |
37 37
38 38
39
-[[include:browser_PTPN1.md]]
39
+[[include:tables/browser_PTPN1.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/PTPN1_by_pathology.svg)
PTPN23.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_PTPN23.md]]
31
+[[include:tables/browser_PTPN23.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/PTPN23_by_pathology.svg)
PTPN6.md
... ...
@@ -25,7 +25,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
25 25
26 26
[[include:tables/dnds_PTPN6.md]]
27 27
28
-[[include:browser_PTPN6.md]]
28
+[[include:tables/browser_PTPN6.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/PTPN6_by_pathology.svg)
PTPRD.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
| :---:| :---: | :--: | :---: |
36 36
| chr9 | 8376670 | T>G | Q1481H |
37 37
38
-[[include:browser_PTPRD.md]]
38
+[[include:tables/browser_PTPRD.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/PTPRD_by_pathology.svg)
PTPRK.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_PTPRK.md]]
36
+[[include:tables/browser_PTPRK.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/PTPRK_by_pathology.svg)
PTPRN.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
32 32
33 33
34
-[[include:browser_PTPRN.md]]
34
+[[include:tables/browser_PTPRN.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/PTPRN_by_pathology.svg)
PXDNL.md
... ...
@@ -34,7 +34,7 @@ nocite: |
34 34
35 35
36 36
37
-[[include:browser_PXDNL.md]]
37
+[[include:tables/browser_PXDNL.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/PXDNL_by_pathology.svg)
PZP.md
... ...
@@ -24,7 +24,7 @@ nocite: |
24 24
25 25
26 26
27
-[[include:browser_PZP.md]]
27
+[[include:tables/browser_PZP.md]]
28 28
29 29
## Expression
30 30
![](images/gene_expression/PZP_by_pathology.svg)
RAC2.md
... ...
@@ -34,7 +34,7 @@ nocite: |
34 34
| chr22 | 37627985 | T>C | N92S |
35 35
| chr22 | 37627985 | T>G | N92T |
36 36
37
-[[include:browser_RAC2.md]]
37
+[[include:tables/browser_RAC2.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/RAC2_by_pathology.svg)
RAD9A.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
[[include:tables/dnds_RAD9A.md]]
27 27
28 28
29
-[[include:browser_RAD9A.md]]
29
+[[include:tables/browser_RAD9A.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/RAD9A_by_pathology.svg)
RANBP6.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
27 27
28 28
29
-[[include:browser_RANBP6.md]]
29
+[[include:tables/browser_RANBP6.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/RANBP6_by_pathology.svg)
RARA.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_RARA.md]]
35
+[[include:tables/browser_RARA.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/RARA_by_pathology.svg)
RB1.md
... ...
@@ -29,7 +29,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
29 29
30 30
[[include:tables/dnds_RB1.md]]
31 31
32
-[[include:browser_RB1.md]]
32
+[[include:tables/browser_RB1.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/RB1_by_pathology.svg)
RBM6.md
... ...
@@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma
27 27
[[include:tables/dnds_RBM6.md]]
28 28
29 29
30
-[[include:browser_RBM6.md]]
30
+[[include:tables/browser_RBM6.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/RBM6_by_pathology.svg)
RBP3.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
32 32
33 33
34
-[[include:browser_RBP3.md]]
34
+[[include:tables/browser_RBP3.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/RBP3_by_pathology.svg)
RET.md
... ...
@@ -36,7 +36,7 @@ Due to [minimal support](RET#representative-mutation) in the original primary da
36 36
37 37
38 38
39
-[[include:browser_RET.md]]
39
+[[include:tables/browser_RET.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/RET_by_pathology.svg)
REV3L.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_REV3L.md]]
30
+[[include:tables/browser_REV3L.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/REV3L_by_pathology.svg)
RFTN1.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_RFTN1.md]]
36
+[[include:tables/browser_RFTN1.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/RFTN1_by_pathology.svg)
RFX7.md
... ...
@@ -33,7 +33,7 @@ Driver mutations affecting this gene in DLBCL/BL have been experimentally demons
33 33
[[include:tables/dnds_RFX7.md]]
34 34
35 35
36
-[[include:browser_RFX7.md]]
36
+[[include:tables/browser_RFX7.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/RFX7_by_pathology.svg)
RFXAP.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_RFXAP.md]]
35
+[[include:tables/browser_RFXAP.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/RFXAP_by_pathology.svg)
RHOA.md
... ...
@@ -40,7 +40,7 @@ Driver mutations affecting this gene in DLBCL/BL have been experimentally demons
40 40
| chr3 | 49412898 | T>G | Y42S |
41 41
| chr3 | 49412898 | T>C | Y42C |
42 42
43
-[[include:browser_RHOA.md]]
43
+[[include:tables/browser_RHOA.md]]
44 44
45 45
## Expression
46 46
![](images/gene_expression/RHOA_by_pathology.svg)
RHOH.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
|chr4 |40193105 |40204231|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr4%3A40193105%2D40204231)|active_promoter |
32 32
33 33
34
-[[include:browser_RHOH.md]]
34
+[[include:tables/browser_RHOH.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/RHOH_by_pathology.svg)
RNF144B.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_RNF144B.md]]
35
+[[include:tables/browser_RNF144B.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/RNF144B_by_pathology.svg)
RPL10.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_RPL10.md]]
30
+[[include:tables/browser_RPL10.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/RPL10_by_pathology.svg)
RRAGC.md
... ...
@@ -28,7 +28,7 @@ Driver mutations affecting this gene in DLBCL/FL have been experimentally demons
28 28
29 29
[[include:tables/dnds_RRAGC.md]]
30 30
31
-[[include:browser_RRAGC.md]]
31
+[[include:tables/browser_RRAGC.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/RRAGC_by_pathology.svg)
RUNX1.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_RUNX1.md]]
36
+[[include:tables/browser_RUNX1.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/RUNX1_by_pathology.svg)
S1PR1.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
27 27
28
-[[include:browser_S1PR1.md]]
28
+[[include:tables/browser_S1PR1.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/S1PR1_by_pathology.svg)
S1PR2.md
... ...
@@ -41,7 +41,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
41 41
|chr19 |10340142 |10341764|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr19%3A10340142%2D10341764)|active_promoter |
42 42
43 43
44
-[[include:browser_S1PR2.md]]
44
+[[include:tables/browser_S1PR2.md]]
45 45
46 46
## Expression
47 47
![](images/gene_expression/S1PR2_by_pathology.svg)
SAL3.md
... ...
@@ -17,7 +17,7 @@ nocite: |
17 17
[[include:tables/BL_SAL3.md]]
18 18
19 19
20
-[[include:browser_SAL3.md]]
20
+[[include:tables/browser_SAL3.md]]
21 21
22 22
## Expression
23 23
![](images/gene_expression/SAL3_by_pathology.svg)
SALL3.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_SALL3.md]]
36
+[[include:tables/browser_SALL3.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/SALL3_by_pathology.svg)
SAMD9L.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_SAMD9L.md]]
30
+[[include:tables/browser_SAMD9L.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/SAMD9L_by_pathology.svg)
SAPS2.md
... ...
@@ -22,7 +22,7 @@ nocite: |
22 22
23 23
[[include:tables/BL_SAPS2.md]]
24 24
25
-[[include:browser_SAPS2.md]]
25
+[[include:tables/browser_SAPS2.md]]
26 26
27 27
## Expression
28 28
![](images/gene_expression/SAPS2_by_pathology.svg)
SARM1.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_SARM1.md]]
31
+[[include:tables/browser_SARM1.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/SARM1_by_pathology.svg)
SBF1.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_SBF1.md]]
30
+[[include:tables/browser_SBF1.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/SBF1_by_pathology.svg)
SEL1L3.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
|chr4 |25861094 |25868788|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr4%3A25861094%2D25868788)|NA |
32 32
33 33
34
-[[include:browser_SEL1L3.md]]
34
+[[include:tables/browser_SEL1L3.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/SEL1L3_by_pathology.svg)
SERPINA9.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_SERPINA9.md]]
36
+[[include:tables/browser_SERPINA9.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/SERPINA9_by_pathology.svg)
SETD1B.md
... ...
@@ -36,7 +36,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
36 36
| chr12 | 122265950 | G>A | A1858T |
37 37
| chr12 | 122265953 | C>T | R1859C |
38 38
39
-[[include:browser_SETD1B.md]]
39
+[[include:tables/browser_SETD1B.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/SETD1B_by_pathology.svg)
SETD2.md
... ...
@@ -32,7 +32,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero
32 32
33 33
34 34
35
-[[include:browser_SETD2.md]]
35
+[[include:tables/browser_SETD2.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/SETD2_by_pathology.svg)
SETD5.md
... ...
@@ -36,7 +36,7 @@ Mutations in this gene were reported to be inflated in the original results acco
36 36
37 37
38 38
39
-[[include:browser_SETD5.md]]
39
+[[include:tables/browser_SETD5.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/SETD5_by_pathology.svg)
SF3B1.md
... ...
@@ -41,7 +41,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
41 41
| chr2 | 198266832 | T>G | K700N |
42 42
| chr2 | 198266821 | A>C | I704S |
43 43
44
-[[include:browser_SF3B1.md]]
44
+[[include:tables/browser_SF3B1.md]]
45 45
46 46
## Expression
47 47
![](images/gene_expression/SF3B1_by_pathology.svg)
SGK1.md
... ...
@@ -42,7 +42,7 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons
42 42
<!-- DLBCL: morinFrequentMutationHistonemodifying2011 -->
43 43
44 44
45
-[[include:browser_SGK1.md]]
45
+[[include:tables/browser_SGK1.md]]
46 46
47 47
48 48
[[include:tables/mermaid_SGK1.md]]
SHANK1.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
32 32
33 33
34
-[[include:browser_SHANK1.md]]
34
+[[include:tables/browser_SHANK1.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/SHANK1_by_pathology.svg)
SHROOM3.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
27 27
28
-[[include:browser_SHROOM3.md]]
28
+[[include:tables/browser_SHROOM3.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/SHROOM3_by_pathology.svg)
SI.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_SI.md]]
31
+[[include:tables/browser_SI.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/SI_by_pathology.svg)
SIAH2.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_SIAH2.md]]
31
+[[include:tables/browser_SIAH2.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/SIAH2_by_pathology.svg)
SIN3A.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
[[include:tables/dnds_SIN3A.md]]
27 27
28
-[[include:browser_SIN3A.md]]
28
+[[include:tables/browser_SIN3A.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/SIN3A_by_pathology.svg)
SLC29A2.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_SLC29A2.md]]
35
+[[include:tables/browser_SLC29A2.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/SLC29A2_by_pathology.svg)
SLC34A2.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
[[include:tables/dnds_SLC34A2.md]]
27 27
28 28
29
-[[include:browser_SLC34A2.md]]
29
+[[include:tables/browser_SLC34A2.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/SLC34A2_by_pathology.svg)
SMARCA4.md
... ...
@@ -40,7 +40,7 @@ Driver mutations affecting this gene in DLBCL/FL/BL have been experimentally dem
40 40
41 41
[[include:tables/dnds_SMARCA4.md]]
42 42
43
-[[include:browser_SMARCA4.md]]
43
+[[include:tables/browser_SMARCA4.md]]
44 44
45 45
## Expression
46 46
![](images/gene_expression/SMARCA4_by_pathology.svg)
SMARCB1.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_SMARCB1.md]]
32
+[[include:tables/browser_SMARCB1.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/SMARCB1_by_pathology.svg)
SMC1A.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_SMC1A.md]]
31
+[[include:tables/browser_SMC1A.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/SMC1A_by_pathology.svg)
SMEK1.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
|FL |No |No |9.566 |58.730 |
31 31
32 32
33
-[[include:browser_SMEK1.md]]
33
+[[include:tables/browser_SMEK1.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/SMEK1_by_pathology.svg)
SNTB2.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
[[include:tables/dnds_SNTB2.md]]
34 34
35 35
36
-[[include:browser_SNTB2.md]]
36
+[[include:tables/browser_SNTB2.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/SNTB2_by_pathology.svg)
SOCS1.md
... ...
@@ -35,7 +35,7 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons
35 35
|chr16 |11347512 |11350007|[intron-1](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr16%3A11347512%2D11350007)|enhancer |
36 36
37 37
38
-[[include:browser_SOCS1.md]]
38
+[[include:tables/browser_SOCS1.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/SOCS1_by_pathology.svg)
SP140.md
... ...
@@ -24,7 +24,7 @@ nocite: |
24 24
25 25
26 26
27
-[[include:browser_SP140.md]]
27
+[[include:tables/browser_SP140.md]]
28 28
29 29
## Expression
30 30
![](images/gene_expression/SP140_by_pathology.svg)
SPEN.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
| chr1 | 16256846 | C>T | R1371* |
30 30
| chr1 | 16261814 | C>T | R3027* |
31 31
32
-[[include:browser_SPEN.md]]
32
+[[include:tables/browser_SPEN.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/SPEN_by_pathology.svg)
SRRM2.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_SRRM2.md]]
31
+[[include:tables/browser_SRRM2.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/SRRM2_by_pathology.svg)
ST6GAL1.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
|chr3 |186782522 |186784438|[intron-1](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr3%3A186782522%2D186784438)|strong_enhancer |
36 36
37 37
38
-[[include:browser_ST6GAL1.md]]
38
+[[include:tables/browser_ST6GAL1.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/ST6GAL1_by_pathology.svg)
STAB2.md
... ...
@@ -24,7 +24,7 @@ nocite: |
24 24
25 25
26 26
27
-[[include:browser_STAB2.md]]
27
+[[include:tables/browser_STAB2.md]]
28 28
29 29
## Expression
30 30
![](images/gene_expression/STAB2_by_pathology.svg)
STAT3.md
... ...
@@ -36,7 +36,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
36 36
| chr17 | 40475318 | C>T | D570N |
37 37
| chr17 | 40475317 | T>C | D570G |
38 38
39
-[[include:browser_STAT3.md]]
39
+[[include:tables/browser_STAT3.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/STAT3_by_pathology.svg)
STAT5B.md
... ...
@@ -32,7 +32,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero
32 32
33 33
34 34
35
-[[include:browser_STAT5B.md]]
35
+[[include:tables/browser_STAT5B.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/STAT5B_by_pathology.svg)
STAT6.md
... ...
@@ -52,7 +52,7 @@ Recurrent mutations at the D419 amino acid residue are a common feature in DLBCL
52 52
| chr12 | 57496656 | T>C | N421D |
53 53
| chr12 | 57496654 | A>C | N421K |
54 54
55
-[[include:browser_STAT6.md]]
55
+[[include:tables/browser_STAT6.md]]
56 56
57 57
## Expression
58 58
![](images/gene_expression/STAT6_by_pathology.svg)
SYK.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_SYK.md]]
31
+[[include:tables/browser_SYK.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/SYK_by_pathology.svg)
SYNE1.md
... ...
@@ -23,7 +23,7 @@ nocite: |
23 23
24 24
25 25
26
-[[include:browser_SYNE1.md]]
26
+[[include:tables/browser_SYNE1.md]]
27 27
28 28
## Expression
29 29
![](images/gene_expression/SYNE1_by_pathology.svg)
SYNGAP1.md
... ...
@@ -34,7 +34,7 @@ Due to [minimal support](SYNGAP1#representative-mutation) in the original primar
34 34
[[include:tables/dnds_SYNGAP1.md]]
35 35
36 36
37
-[[include:browser_SYNGAP1.md]]
37
+[[include:tables/browser_SYNGAP1.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/SYNGAP1_by_pathology.svg)
SYPL1.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_SYPL1.md]]
30
+[[include:tables/browser_SYPL1.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/SYPL1_by_pathology.svg)
TAF1.md
... ...
@@ -22,7 +22,7 @@ nocite: |
22 22
[[include:tables/dnds_TAF1.md]]
23 23
24 24
25
-[[include:browser_TAF1.md]]
25
+[[include:tables/browser_TAF1.md]]
26 26
27 27
## Expression
28 28
![](images/gene_expression/TAF1_by_pathology.svg)
TAP1.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
[[include:tables/dnds_TAP1.md]]
27 27
28
-[[include:browser_TAP1.md]]
28
+[[include:tables/browser_TAP1.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/TAP1_by_pathology.svg)
TBC1D26.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_TBC1D26.md]]
32
+[[include:tables/browser_TBC1D26.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/TBC1D26_by_pathology.svg)
TBC1D4.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
|chr13 |75982519 |75986015|[intron](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr13%3A75982519%2D75986015)|NA |
33 33
34 34
35
-[[include:browser_TBC1D4.md]]
35
+[[include:tables/browser_TBC1D4.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/TBC1D4_by_pathology.svg)
TBC1D9B.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
[[include:tables/dnds_TBC1D9B.md]]
31 31
32 32
33
-[[include:browser_TBC1D9B.md]]
33
+[[include:tables/browser_TBC1D9B.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/TBC1D9B_by_pathology.svg)
TBL1XR1.md
... ...
@@ -41,7 +41,7 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons
41 41
| chr3 | 176750838 | T>C | Y446C |
42 42
| chr3 | 176750836 | T>G | S447R |
43 43
44
-[[include:browser_TBL1XR1.md]]
44
+[[include:tables/browser_TBL1XR1.md]]
45 45
46 46
## Expression
47 47
![](images/gene_expression/TBL1XR1_by_pathology.svg)
TCF3.md
... ...
@@ -42,7 +42,7 @@ Driver mutations affecting this gene in BL have been experimentally demonstrated
42 42
| chr19 | 1612336 | A>C | D561E |
43 43
| chr19 | 1612329 | C>T | E564K |
44 44
45
-[[include:browser_TCF3.md]]
45
+[[include:tables/browser_TCF3.md]]
46 46
47 47
## Expression
48 48
![](images/gene_expression/TCF3_by_pathology.svg)
TCL1A.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_TCL1A.md]]
36
+[[include:tables/browser_TCL1A.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/TCL1A_by_pathology.svg)
TERT.md
... ...
@@ -26,7 +26,7 @@ Non-coding mutations in the promoter of this gene have been described in MCL.
26 26
27 27
28 28
29
-[[include:browser_TERT.md]]
29
+[[include:tables/browser_TERT.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/TERT_by_pathology.svg)
TET2.md
... ...
@@ -26,7 +26,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
26 26
27 27
[[include:tables/dnds_TET2.md]]
28 28
29
-[[include:browser_TET2.md]]
29
+[[include:tables/browser_TET2.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/TET2_by_pathology.svg)
TFAP4.md
... ...
@@ -32,7 +32,7 @@ Driver mutations affecting this gene in BL have been experimentally demonstrated
32 32
33 33
[[include:tables/dnds_TFAP4.md]]
34 34
35
-[[include:browser_TFAP4.md]]
35
+[[include:tables/browser_TFAP4.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/TFAP4_by_pathology.svg)
TGFBR2.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_TGFBR2.md]]
31
+[[include:tables/browser_TGFBR2.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/TGFBR2_by_pathology.svg)
TIGD6.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
32 32
33 33
34
-[[include:browser_TIGD6.md]]
34
+[[include:tables/browser_TIGD6.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/TIGD6_by_pathology.svg)
TIPARP.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_TIPARP.md]]
31
+[[include:tables/browser_TIPARP.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/TIPARP_by_pathology.svg)
TLR2.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
| chr4 | 154625039 | A>T | D327V |
32 32
| chr4 | 154625042 | T>G | L328R |
33 33
34
-[[include:browser_TLR2.md]]
34
+[[include:tables/browser_TLR2.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/TLR2_by_pathology.svg)
TMEM30A.md
... ...
@@ -37,7 +37,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
37 37
| chr6 | 75965985 | G>A | R307* |
38 38
| chr6 | 75965975 | A>T | M310K |
39 39
40
-[[include:browser_TMEM30A.md]]
40
+[[include:tables/browser_TMEM30A.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/TMEM30A_by_pathology.svg)
TMSB4X.md
... ...
@@ -36,7 +36,7 @@ TMSB4X is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm
36 36
37 37
38 38
39
-[[include:browser_TMSB4X.md]]
39
+[[include:tables/browser_TMSB4X.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/TMSB4X_by_pathology.svg)
TNFAIP3.md
... ...
@@ -36,7 +36,7 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons
36 36
| chr6 | 138198218 | C>T | R271* |
37 37
| chr6 | 138198246 | G>A | R280Q |
38 38
39
-[[include:browser_TNFAIP3.md]]
39
+[[include:tables/browser_TNFAIP3.md]]
40 40
41 41
## Expression
42 42
TNFRSF14.md
... ...
@@ -47,7 +47,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
47 47
| chr1 | 2488152 | A>T | K17* |
48 48
| chr1 | 2488156 | C>A | T18N |
49 49
50
-[[include:browser_TNFRSF14.md]]
50
+[[include:tables/browser_TNFRSF14.md]]
51 51
52 52
## Expression
53 53
![](images/gene_expression/TNFRSF14_by_pathology.svg)
TOP2A.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_TOP2A.md]]
30
+[[include:tables/browser_TOP2A.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/TOP2A_by_pathology.svg)
TOX.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
| chr8 | 60031445 | C>T | K34= |
30 30
| chr8 | 60031446 | T>G | K34T |
31 31
32
-[[include:browser_TOX.md]]
32
+[[include:tables/browser_TOX.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/TOX_by_pathology.svg)
TP53.md
... ...
@@ -35,7 +35,7 @@ Driver mutations affecting this gene in BL/FL/DLBCL have been experimentally dem
35 35
36 36
[[include:tables/dnds_TP53.md]]
37 37
38
-[[include:browser_TP53.md]]
38
+[[include:tables/browser_TP53.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/TP53_by_pathology.svg)
TPP1.md
... ...
@@ -25,7 +25,7 @@ nocite: |
25 25
26 26
27 27
28
-[[include:browser_TPP1.md]]
28
+[[include:tables/browser_TPP1.md]]
29 29
30 30
## Expression
31 31
![](images/gene_expression/TPP1_by_pathology.svg)
TPST2.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_TPST2.md]]
35
+[[include:tables/browser_TPST2.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/TPST2_by_pathology.svg)
TRAF3.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
## Visualizations
29 29
30
-[[include:browser_TRAF3.md]]
30
+[[include:tables/browser_TRAF3.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/TRAF3_by_pathology.svg)
TRAF6.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
| chr11 | 36511893 | C>T | W355* |
36 36
| chr11 | 36511892 | C>T | W355* |
37 37
38
-[[include:browser_TRAF6.md]]
38
+[[include:tables/browser_TRAF6.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/TRAF6_by_pathology.svg)
TRIP12.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_TRIP12.md]]
35
+[[include:tables/browser_TRIP12.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/TRIP12_by_pathology.svg)
TRRAP.md
... ...
@@ -34,7 +34,7 @@ nocite: |
34 34
| :---:| :---: | :--: | :---: |
35 35
| chr7 | 98509802 | C>T | S722F |
36 36
37
-[[include:browser_TRRAP.md]]
37
+[[include:tables/browser_TRRAP.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/TRRAP_by_pathology.svg)
TTN.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
| :---:| :---: | :--: | :---: |
32 32
| chr2 | 179638249 | C>T | E2512K |
33 33
34
-[[include:browser_TTN.md]]
34
+[[include:tables/browser_TTN.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/TTN_by_pathology.svg)
UBE2A.md
... ...
@@ -21,7 +21,7 @@ nocite: |
21 21
22 22
[[include:tables/dnds_UBE2A.md]]
23 23
24
-[[include:browser_UBE2A.md]]
24
+[[include:tables/browser_UBE2A.md]]
25 25
26 26
## Expression
27 27
![](images/gene_expression/UBE2A_by_pathology.svg)
UBE2J1.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
|chr6 |90059730 |90063703|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr6%3A90059730%2D90063703)|NA |
32 32
33 33
34
-[[include:browser_UBE2J1.md]]
34
+[[include:tables/browser_UBE2J1.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/UBE2J1_by_pathology.svg)
UBR5.md
... ...
@@ -32,7 +32,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero
32 32
33 33
34 34
35
-[[include:browser_UBR5.md]]
35
+[[include:tables/browser_UBR5.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/UBR5_by_pathology.svg)
UNC5B.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
[[include:tables/dnds_UNC5B.md]]
27 27
28 28
29
-[[include:browser_UNC5B.md]]
29
+[[include:tables/browser_UNC5B.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/UNC5B_by_pathology.svg)
UNC5C.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_UNC5C.md]]
30
+[[include:tables/browser_UNC5C.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/UNC5C_by_pathology.svg)
UNC5D.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
27 27
28 28
29
-[[include:browser_UNC5D.md]]
29
+[[include:tables/browser_UNC5D.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/UNC5D_by_pathology.svg)
USP7.md
... ...
@@ -24,7 +24,7 @@ nocite: |
24 24
25 25
[[include:tables/dnds_USP7.md]]
26 26
27
-[[include:browser_USP7.md]]
27
+[[include:tables/browser_USP7.md]]
28 28
29 29
## Expression
30 30
![](images/gene_expression/USP7_by_pathology.svg)
VMA21.md
... ...
@@ -30,7 +30,7 @@ Driver mutations affecting this gene in FL have been experimentally demonstrated
30 30
31 31
[[include:tables/dnds_VMA21.md]]
32 32
33
-[[include:browser_VMA21.md]]
33
+[[include:tables/browser_VMA21.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/VMA21_by_pathology.svg)
VPS13B.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
| :---:| :---: | :--: | :---: |
38 38
| chr8 | 100829860 | A>T | Q2755H |
39 39
40
-[[include:browser_VPS13B.md]]
40
+[[include:tables/browser_VPS13B.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/VPS13B_by_pathology.svg)
VWA7.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_VWA7.md]]
30
+[[include:tables/browser_VWA7.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/VWA7_by_pathology.svg)
WAC.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_WAC.md]]
36
+[[include:tables/browser_WAC.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/WAC_by_pathology.svg)
WDFY3.md
... ...
@@ -28,7 +28,7 @@ nocite: |
28 28
29 29
30 30
31
-[[include:browser_WDFY3.md]]
31
+[[include:tables/browser_WDFY3.md]]
32 32
33 33
## Expression
34 34
![](images/gene_expression/WDFY3_by_pathology.svg)
WDR7.md
... ...
@@ -35,7 +35,7 @@ nocite: |
35 35
36 36
37 37
38
-[[include:browser_WDR7.md]]
38
+[[include:tables/browser_WDR7.md]]
39 39
40 40
## Expression
41 41
![](images/gene_expression/WDR7_by_pathology.svg)
WDR90.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_WDR90.md]]
30
+[[include:tables/browser_WDR90.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/WDR90_by_pathology.svg)
WEE1.md
... ...
@@ -41,7 +41,7 @@ WEE1 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)
41 41
| chr11 | 9595888 | C>G | S136R |
42 42
| chr11 | 9595889 | T>G | S137A |
43 43
44
-[[include:browser_WEE1.md]]
44
+[[include:tables/browser_WEE1.md]]
45 45
46 46
## Expression
47 47
![](images/gene_expression/WEE1_by_pathology.svg)
WHAMM.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
27 27
28 28
29
-[[include:browser_WHAMM.md]]
29
+[[include:tables/browser_WHAMM.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/WHAMM_by_pathology.svg)
WNK1.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
| :---:| :---: | :--: | :---: |
31 31
| chr12 | 968467 | G>A | R486Q |
32 32
33
-[[include:browser_WNK1.md]]
33
+[[include:tables/browser_WNK1.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/WNK1_by_pathology.svg)
WNK2.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
| :---:| :---: | :--: | :---: |
34 34
| chr9 | 96031211 | G>A | A1375T |
35 35
36
-[[include:browser_WNK2.md]]
36
+[[include:tables/browser_WNK2.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/WNK2_by_pathology.svg)
XBP1.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
|chr22 |29194943 |29197461|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr22%3A29194943%2D29197461)|NA |
38 38
39 39
40
-[[include:browser_XBP1.md]]
40
+[[include:tables/browser_XBP1.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/XBP1_by_pathology.svg)
XIRP2.md
... ...
@@ -31,7 +31,7 @@ nocite: |
31 31
| :---:| :---: | :--: | :---: |
32 32
| chr2 | 168107297 | G>A | R3132Q |
33 33
34
-[[include:browser_XIRP2.md]]
34
+[[include:tables/browser_XIRP2.md]]
35 35
36 36
## Expression
37 37
![](images/gene_expression/XIRP2_by_pathology.svg)
XPO1.md
... ...
@@ -33,7 +33,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
33 33
| chr2 | 61719471 | T>C | E571G |
34 34
| chr2 | 61719472 | C>T | E571K |
35 35
36
-[[include:browser_XPO1.md]]
36
+[[include:tables/browser_XPO1.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/XPO1_by_pathology.svg)
YY1.md
... ...
@@ -36,7 +36,7 @@ Mutations in this gene were reported to be inflated in the original results acco
36 36
37 37
38 38
39
-[[include:browser_YY1.md]]
39
+[[include:tables/browser_YY1.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/YY1_by_pathology.svg)
YY1AP1.md
... ...
@@ -27,7 +27,7 @@ nocite: |
27 27
28 28
29 29
30
-[[include:browser_YY1AP1.md]]
30
+[[include:tables/browser_YY1AP1.md]]
31 31
32 32
## Expression
33 33
![](images/gene_expression/YY1AP1_by_pathology.svg)
ZAN.md
... ...
@@ -26,7 +26,7 @@ nocite: |
26 26
27 27
28 28
29
-[[include:browser_ZAN.md]]
29
+[[include:tables/browser_ZAN.md]]
30 30
31 31
## Expression
32 32
![](images/gene_expression/ZAN_by_pathology.svg)
ZBTB7A.md
... ...
@@ -37,7 +37,7 @@ nocite: |
37 37
38 38
39 39
40
-[[include:browser_ZBTB7A.md]]
40
+[[include:tables/browser_ZBTB7A.md]]
41 41
42 42
## Expression
43 43
![](images/gene_expression/ZBTB7A_by_pathology.svg)
ZC3H12A.md
... ...
@@ -29,7 +29,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
29 29
30 30
[[include:tables/dnds_ZC3H12A.md]]
31 31
32
-[[include:browser_ZC3H12A.md]]
32
+[[include:tables/browser_ZC3H12A.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/ZC3H12A_by_pathology.svg)
ZCCHC7.md
... ...
@@ -33,7 +33,7 @@ nocite: |
33 33
34 34
35 35
36
-[[include:browser_ZCCHC7.md]]
36
+[[include:tables/browser_ZCCHC7.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/ZCCHC7_by_pathology.svg)
ZEB2.md
... ...
@@ -33,7 +33,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero
33 33
34 34
35 35
36
-[[include:browser_ZEB2.md]]
36
+[[include:tables/browser_ZEB2.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/ZEB2_by_pathology.svg)
ZFAT.md
... ...
@@ -32,7 +32,7 @@ nocite: |
32 32
33 33
34 34
35
-[[include:browser_ZFAT.md]]
35
+[[include:tables/browser_ZFAT.md]]
36 36
37 37
## Expression
38 38
![](images/gene_expression/ZFAT_by_pathology.svg)
ZFP36L1.md
... ...
@@ -34,7 +34,7 @@ ZFP36L1 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ash
34 34
|chr14 |69257848 |69259739|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr14%3A69257848%2D69259739)|active_promoter |
35 35
36 36
37
-[[include:browser_ZFP36L1.md]]
37
+[[include:tables/browser_ZFP36L1.md]]
38 38
39 39
## Expression
40 40
![](images/gene_expression/ZFP36L1_by_pathology.svg)
ZFX.md
... ...
@@ -36,7 +36,7 @@ Mutations in this gene were reported to be inflated in the original results acco
36 36
37 37
38 38
39
-[[include:browser_ZFX.md]]
39
+[[include:tables/browser_ZFX.md]]
40 40
41 41
## Expression
42 42
![](images/gene_expression/ZFX_by_pathology.svg)
ZNF117.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_ZNF117.md]]
32
+[[include:tables/browser_ZNF117.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/ZNF117_by_pathology.svg)
ZNF217.md
... ...
@@ -30,7 +30,7 @@ nocite: |
30 30
31 31
32 32
33
-[[include:browser_ZNF217.md]]
33
+[[include:tables/browser_ZNF217.md]]
34 34
35 35
## Expression
36 36
![](images/gene_expression/ZNF217_by_pathology.svg)
ZNF229.md
... ...
@@ -33,7 +33,7 @@ Due to [minimal support](ZNF229#representative-mutation) in the original primary
33 33
34 34
35 35
36
-[[include:browser_ZNF229.md]]
36
+[[include:tables/browser_ZNF229.md]]
37 37
38 38
## Expression
39 39
![](images/gene_expression/ZNF229_by_pathology.svg)
ZNF292.md
... ...
@@ -21,7 +21,7 @@ nocite: |
21 21
22 22
[[include:tables/dnds_ZNF292.md]]
23 23
24
-[[include:browser_ZNF292.md]]
24
+[[include:tables/browser_ZNF292.md]]
25 25
26 26
## Expression
27 27
![](images/gene_expression/ZNF292_by_pathology.svg)
ZNF296.md
... ...
@@ -29,7 +29,7 @@ nocite: |
29 29
30 30
31 31
32
-[[include:browser_ZNF296.md]]
32
+[[include:tables/browser_ZNF296.md]]
33 33
34 34
## Expression
35 35
![](images/gene_expression/ZNF296_by_pathology.svg)
ZNF423.md
... ...
@@ -24,7 +24,7 @@ nocite: |
24 24
25 25
26 26
27
-[[include:browser_ZNF423.md]]
27
+[[include:tables/browser_ZNF423.md]]
28 28
29 29
## Expression
30 30
![](images/gene_expression/ZNF423_by_pathology.svg)
ZNF608.md
... ...
@@ -24,7 +24,7 @@ nocite: |
24 24
25 25
[[include:tables/dnds_ZNF608.md]]
26 26
27
-[[include:browser_ZNF608.md]]
27
+[[include:tables/browser_ZNF608.md]]
28 28
29 29
## Expression
30 30
![](images/gene_expression/ZNF608_by_pathology.svg)
ZNF85.md
... ...
@@ -24,7 +24,7 @@ nocite: |
24 24
25 25
26 26
27
-[[include:browser_ZNF85.md]]
27
+[[include:tables/browser_ZNF85.md]]
28 28
29 29
## Expression
30 30
![](images/gene_expression/ZNF85_by_pathology.svg)